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ABSTRACT 
 
Effects of Bran from Sorghum Grains Containing Different Classes and Levels of 
Bioactive Compounds in Colon Carcinogenesis. (December 2008) 
Jayme Beth Lewis, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Nancy D. Turner 
 
 In order to test the dietary effects of bioactive compounds present in whole 
grains, we decided to observe the effect of varying types of sorghum bran on colon 
cancer promotion.  We used 40 rats consuming diets containing 6% fiber from either 
cellulose or bran from white (contains phenolic acids), brown (contains tannins), or 
black (contains anthocyanins) sorghum (n=10).  Diets were fed for 10 wk, during which 
two azoxymethane (AOM) injections (15 mg/kg BW) were administered in wk 3 and 4.   
 We observed that the total number of aberrant crypts (AC) and high multiplicity 
aberrant crypt foci (HMACF) were lower in rats consuming black (p < 0.04) and brown 
(p < 0.006) sorghum diets when compared to the cellulose diet, and that these decreases 
were an inverse function of diet antioxidant activity (ABTS).  These observations led us 
to evaluate the effect of these diets on endogenous enzymatic activities (superoxide 
dismutase, SOD; catalase, CAT; and glutathione peroxidase, GPx), redox status as 
measured by reduced and oxidized glutathione, and cell cycle processes, proliferation 
and apoptosis, in the rat colon.  Total SOD activity was higher (p < 0.04) in rats 
consuming black sorghum when compared to all other diets.  A similar, but not 
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significant, trend occurred in mitochondrial SOD.  The white sorghum diet had enhanced 
(p < 0.02) CAT activity compared to the cellulose diet, but the black and brown sorghum 
diets were intermediate.  Finally, all sorghum diets suppressed GPx activity relative to 
cellulose (p < 0.04).  However, no changes were seen in levels of reduced and oxidized 
glutathione or the ratio of the two.   
 The black sorghum fed rats had a lower proliferative index (p < 0.01) and zone (p 
< 0.04) compared to cellulose; brown and white sorghum rats were intermediate.  
Apoptotic index was highest in brown sorghum rats compared to cellulose (p < 0.03), 
while other sorghum diets were intermediate.  These data suggest that the suppression of 
AC and HMACF formation in rats consuming sorghum bran may have resulted through 
the differential actions of the sorghum brans on endogenous antioxidant enzymes, which 
may affect colonocyte proliferation and apoptosis.   
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CHAPTER I 
INTRODUCTION1 
 
 In the past decade, cancer passed heart disease as the leading cause of death 
among Americans under the age of 85 (1).  Among cancer-related deaths, colon cancer is 
second to lung cancer as the primary cause of death (2).  It is notably influenced by 
environmental factors, such as diet (3, 4).  Research has shown that whole grain 
consumption is favorable in the prevention of diseases, such as gastrointestinal      
cancers (5).  Whole grains provide a sufficient amount of dietary fiber, which acts as a 
bulking agent and its fermentation in the colon produces a lower pH and short chain fatty 
acids, both of which seem to be protective (6, 7).  Schatzkin et al (8) found an inverse 
relationship with the consumption of whole grains and the relative risk of colorectal 
cancer among a cohort of men and women.  However, when colorectal cancer risk was 
further examined at a dietary fiber level, no association was found.  This suggests that 
other whole grain components might be working with fiber to produce the prevention of 
colorectal cancer. 
 Whole grains contain other health-promoting constituents such as vitamins, 
minerals, and bioactive compounds.  Bioactive compounds are non-nutritive substances 
derived from plants that possess cholesterol-lowering properties, antioxidant capacity, 
and have the potential to be chemoprotective (9, 10).  Perhaps these compounds are 
aiding in protection against colorectal cancer, either directly or through a synergistic 
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effect with dietary fiber.  Nevertheless, more research is needed in order to determine the 
precise mechanisms whereby whole grains contribute to colon cancer prevention. 
 In order to address this issue, we chose to investigate the chemoprotective 
properties of sorghum grain.  Sorghum is a grain commonly consumed in parts of Africa 
and Asia, but its main use in the United States is for animal feed.  It is a robust cereal, 
able to outperform other grains in environmental stress (11, 12).  Sorghum contains 
assorted classes and levels of bioactive compounds in its bran, varying by type, making 
it an ideal candidate to study differences in effects of these compounds.  In vitro 
measurements of antioxidant activity (ORAC) show that sorghum possesses significantly 
higher levels than fruits, such as blueberries and strawberries (9).   
 In the 1971, Burkitt (13) observed that on a world list of incidence rates for 
colorectal cancer, a population in Uganda was at the bottom, along with three other 
African populations just above, while Western populations showed up to ten times 
greater incidence rates.  These African populations are the same groups who have been 
consuming sorghum as a staple in their diet for generations.  He postulated that the 
removal of dietary fiber from diets in developed countries was the causative agent of the 
higher incidences of colorectal cancer.  However, it is a possibility that this lower 
incidence of colorectal cancer attributable to African civilizations was more than just a 
dietary fiber effect. 
  In its history, sorghum has been associated with lower incidences of esophageal 
cancer in diverse parts of the world that consume it frequently (14, 15).  However, these 
observations seen in esophageal cancer have yet to be explored with regard to other 
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cancer types even though investigation is merited.  In fact, relatively little research exists 
concerning sorghum relative to human health in general when compared with other 
bioactive compound-containing foods, such as fruits and vegetables.  Thus, more 
exploration of this grain is needed in order to clear up our understanding of colon cancer 
prevention with regard to consumption of whole grains, dietary fiber, and bioactive 
compounds. 
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CHAPTER II 
LITERATURE REVIEW 
 
 Promotion of Colon Carcinogenesis. Colon carcinogenesis is a complex, 
multistep process in which specific histopathlogical transitions occur over an extended 
amount of time, eventually leading to a fully malignant state.  Human tumors have 
demonstrated that mutations derived from genetic predispositions, environmental 
factors, or the interactions between the two are what seem to drive this process (16, 17).  
When oncogenes are activated, they promote the malignant phenotype of cancer, while 
at the same time they can inhibit important tumor-suppressor (18).  For example, 
inhibition of the tumor-suppressor gene adenomatous polyposis coli (APC), which 
regulates oncogenic -catenin, can facilitate the mutation of a normal intestinal epithelial 
cell to a preneoplastic lesion of colon cancer (17).   
 Once an initial mutation has occurred, altered cells have a selected growth 
advantage, allowing the transformed cell type to replicate and further promote colon 
carcinogenesis (19).  However, chemoprotective agents could be introduced in this 
promotion stage in order to reverse the detrimental processes through repair 
mechanisms, such as DNA repair or programmed cell death.  Thus, tactics for 
prevention, such as diet, are vital at this stage of colon carcinogenesis in order to avert 
preneoplastic lesions from developing (20). 
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 Aberrant Crypts. Although there is debate about the validity of aberrant crypt 
foci (ACF) as a colon cancer biomarker (21), these are considered to be preneoplastic 
lesions and are used as a biomarker for carcinogenesis induced by azoxymethane (AOM) 
in rat colons.  They are also found in individuals who are at high risk for developing 
colon cancer (22-25).  As compared to measuring actual tumor incidence for an 
endpoint, ACF measurements decrease the duration needed for the animal studies and 
thus cost while still providing a consistent, quantitative approach for colon cancer risk 
assessment.  Colonic tissue is stained with methylene blue and examined for crypts 
which exhibit increased size, irregular luminal opening, and thicker epithelial lining 
(26).  ACF are specific to colon carcinogenesis and the quantity and multiplicity of ACF 
numerically increase over time as an indicator of colon cancer development in animals 
(22, 27, 28).  On top of this, ACF colonocytes have been shown to exhibit an increase in 
proliferation and an antagonism towards apoptosis (29, 30). 
 
 Proliferation and Apoptosis. Apoptosis is a form of programmed cell death by 
which cells are removed from the body.  On the other hand, proliferation is the process 
of normal cell growth, but when upregulated as in malignant cell types, it leads to 
unrestricted cell division and tumor formation.  In fact, common features of 
adenomatous polyps are unrestricted division of cells and the failure of these cells to 
differentiate properly (19).  In view of this, the dynamic balance between cell death and 
cell survival plays a normal physiological role in regards of the shaping of organs and 
digits as well as the development the nervous and immune system (31).  This balance is 
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also vital for protection against diseases and when this balance is perturbed, 
pathogenesis occurs (6, 31-33).  For example, an increase in cell death is associated with 
AIDS, Parkinson’s disease, Alzheimer’s disease, and others.  Conversely, a suppression 
or inhibition of apoptosis allows cells with genetic abnormalities, such as occurs in 
cancer, to survive (31).   
 A study done on human colonic epithelium showed a relationship between 
transformation of normal tissue to carcinomas and inhibition of apoptosis (34).  Shpitz et 
al (30) demonstrated increased proliferative activity as a characteristic at each stage of 
neoplastic colonic lesions from human specimens, ranging from aberrant crypt foci to 
adenocarcinomas.  However, proliferation can be misleading because cell replication 
alone does not necessarily indicate carcinogenesis, but it allows for the increased 
possibility of mutagenesis (30, 35).  Chang et al (36) previously demonstrated that 
apoptosis was the overall best indicator of colonic tumor development when comparing 
measurements of cell proliferation, differentiation, and apoptosis. 
Apoptosis is a distinct process where the cell shrinks, chromatin condenses, 
membrane surfaces bleb, and the DNA fragments after which the apoptotic body is 
usually phagocytosed by surrounding cells (31, 37).  Studies have shown that apoptosis 
can be mediated by reactive oxygen species (ROS) (38), yet ROS are also thought to 
promote carcinogenesis through interference with signal cascade systems (NFB, AP-1, 
MAPKs) and by induction of DNA damage (37, 39-41).  Mitogen-activated protein 
kinases (MAPKs) can be activated by growth factors and external stimuli via signaling 
cascades to influence cell proliferation.  The pathway in which they are involved also 
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includes proto-oncogene products, Ras and Raf-1, and thus they are associated with 
carcinogenesis (39).  When inadequately regulated, transcription factors nuclear factor- 
kappa B (NFB) and activator protein-1 (AP-1) are associated with tumor promotion in 
that they activate cell proliferation in cells that otherwise would not survive (40). 
 
 Reactive Oxygen Species and Endogenous Antioxidants. ROS include the 
superoxide anion (O2˙-), hydrogen peroxide (H2O2), and the hydroxyl radical (.OH).  
They are formed as byproducts in metabolic processes throughout the body, especially in 
the mitochondria at the site of the electron transport chain.  These molecules can be 
damaging to the DNA of the cell and can compromise cell integrity (42, 43).  As a first 
line of defense, the body has an endogeneous antioxidant defense system of enzymes 
that are imperative for the inhibition of mutagens and protection against oxidative injury 
(44). 
 There are three isoforms of the superoxide dismutase (SOD): cytosolic (Cu/Zn-
SOD), mitochondrial (Mn-SOD), and extracellular (EC-SOD).  Cu/Zn SOD has two 
identical subunits, each containing a copper and a zinc atom associated together with a 
histamine residue.  Mn-SOD is a homotetramer containing one manganese on each 
subunit.  EC-SOD is a tetrameric glycoprotein, containing copper and zinc found in the 
interstitial spaces and extracellular fluid (45). 
 SOD will transform the O2˙- into H2O2.  Superoxide anion is a highly reactive 
molecule that cannot cross cell membranes while H2O2 is able to traverse membranes 
and interact with metals (Fe2+ or Cu+) via the Fenton reaction to form hydroxyl radicals 
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(37).  However, both catalase (CAT) and glutathione peroxidase (GPx) are able to 
quench H2O2 to prevent damage.  CAT is a homotetramer containing one 
ferriprotoporphyrin ring and it efficiently catalyzes the reaction to transform H2O2 into 
water and molecular oxygen (46).  GPx is also a homotetramer containing a 
selenocysteine in each subunit, which is crucial for its peroxidase activity, which reduces 
hydroperoxides with the aid of glutathione (37, 45).  Glutathione (GSH) is a thiol 
belonging to the secondary defense system against free radicals.  It can also be readily 
oxidized to the disulfide (GSSG).  The redox state of glutathione is also an indicator of 
the redox status of the cell and decreased GSH is a marker of oxidative stress and 
pathological conditions (47).   
 ROS are generally understood to be disease-promoting; however, more data have 
shown that they can have beneficial functions such as playing a role in apoptosis (38, 
48).  Nevertheless, individuals that produce excess ROS could be at higher risk for 
developing cancer and would benefit from exogeneous antioxidants, which are able to 
influence the level and activity of both ROS and endogenous antioxidants (38).  Cellular 
antioxidants do not completely remove ROS from the cells, but they contribute to the 
balance needed in order for normal cell function to be maintained (48). 
 
 Sorghum and Its Chemoprotective Capability. Recent research has shown that 
the consumption of whole grains is beneficial in prevention of disease, including 
gastrointestinal cancers (5).  In the past, this effect of whole grain has been attributed to 
dietary fiber and scientists have observed a lower risk of colon cancer in populations of 
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Africa and China who consume diets high in fiber-rich whole grains (13).  However, 
short-term clinical research has shown inconsistent results in regard to this hypothesis 
(30).  Recently, the idea of the interaction of all the whole grain components working 
synergistically to cause the effect, as opposed to dietary fiber working alone, was 
proposed (49).  Whole grains contain bioactive compounds, which give rise to anti-
cancer capabilities, including antioxidant activity.  In order to study how these 
compounds could be working to improve chemoprevention, we decided to examine a 
staple grain of the populations where the original effect was observed. 
 Being that it is a robust grain in environmental stress, sorghum has remained a 
principal food in developing parts of Africa and Asia (11, 12).  It is the fifth leading 
cereal crop in the world, yet in the United States we rarely consume it.  Sorghum is used 
in some gluten-free products for treatment of celiac patients (50); however, most of the 
product is used for animal feed   Even in the scientific realm, relatively little research has 
been done concerning this grain in regards to human health (51).  Though sorghum goes 
unrecognized for the most part, it offers great potential in the area of antioxidant 
capability and chemoprevention.   
 Sorghum contains various bioactive compounds such as phenolic compounds, 
plant sterols and policostanols (9, 52).  Plant sterols can reduce cholesterol absorption 
and policostanols may inhibit endogenous cholesterol synthesis (51).  Phenolic 
compounds, defined as a compound containing a benzene ring with one or more 
hydroxyl groups, fall into two major categories: phenolic acids (cinnamic and benzoic 
acid derivatives) and flavonoids (include tannins and anthocyanins).  These compounds 
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can be concentrated by decorticating the sorghum grain, producing bran to be used in 
diet (9, 53).   
 Phenols present in cocoa, similar in structure to those in sorghum, have shown 
positive health benefits such as reducing blood pressure (54), atherosclerosis (55), and 
growth of human breast cancer cells (56).  Various sorghum brans have demonstrated 
much higher oxygen radical absorbance capacity (ORAC) levels on a dry matter basis 
than those in beneficial fruits such as blueberries and strawberries (9).  Previous data 
from our lab demonstrated that flavonoids similar to those found in sorghum that were 
isolated from citrus, apigenin and naringenin, were able to decrease the formation of 
high multiplicity aberrant crypt foci (ACF), increase apoptotic index, and naringenin was 
able to decrease proliferation (28, 57). 
Sorghums can be classified based on their appearance and level of phenolic 
compounds (Fig. 1).  White sorghums contain small amounts of phenols, mostly as 
bound phenolic acids esterified to cell walls.  Bound phenolic acids are important for 
antioxidant activity in cereals with low levels of flavonoids.  Black sorghums contain 
high levels of 3-deoxyanthocyanins, the two most common being apigenidin and 
luteolinindin (58, 59).  The 3-deoxyanthocyanins contain two aromatic rings that are 
able to stabilize a free radical.  They also lack a hydroxyl group at the 3 position which 
is believed to increase their stability at high pH (60).  Brown sorghums contain high 
levels of condensed tannins, which produce astringency in foods and beverages, such as 
dark chocolate and wine (53).  Brown sorghums also demonstrate the highest antioxidant 
activities when compared to non-tannin sorghums (9).  Tannins show the highest level of 
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antioxidant activity in vitro when compared with all other natural antioxidants.  This is 
because they possess a high number of aromatic rings with hydroxyl groups which can 
stabilize free radicals (9, 52).  
 
 
   
 
 
 
 
 
 
 
 
FIGURE 1 Examples of Bioactive Compounds.  (A) Example of a phenolic acid, 
usually found in white sorghums.  (B) Example of an anthocyanidin, typically found in 
black sorghums.  (C) Example of a condensed tannin, found in brown sorghums.  
Pictures provided by Dr. L.W. Rooney. 
  
 
 Hypothesis. We hypothesized that the bioactive compounds present in the bran 
of brown (contains condensed tannins) and black (contains anthocyanins) sorghums 
would reduce the formation of preneoplastic lesions of colon cancer via changes in cell 
death and cell survival and/or colonic redox environment. 
 
 
A 
C 
B 
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 Specific Aims. The specific aims of this project were to: 
• Determine if the level and/or type of bioactive compounds present in the 
sorghum brans would have an effect on development of preneoplastic lesions 
of colon cancer. 
• Determine if diet effects on preneoplastic lesion development could be due to 
changes in cellular proliferation and apoptosis. 
• Determine if the level and/or type of bioactive compounds contributed by the 
different sorghum brans affected the redox environment of the colonocyte as 
a result of adjustments in the activity of antioxidant enzymes (superoxide 
dismutase, catalase, glutathione peroxidase) or the level of reduced and 
oxidized glutathione. 
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CHAPTER III 
MATERIALS AND METHODS 
 
 Experimental Design. The University Animal Care Committee of Texas A&M 
University approved the supervision put forth by the animal protocols of this study, 
which followed the guidelines of the National Institute of Health.  This experiment used 
40 male weanling (21-d old) Sprague-Dawley rats (Harlan Sprague Dawley, Houston, 
TX).  Rats resided in a temperature (18-26° C) and humidity controlled environment 
with a 12 h light/dark cycle in individual raised wire cages.  After arrival, rats were 
randomized into four different diet groups (n=10/group) subsequent to stratification by 
weight.  Experimental diets and water were provided ad libitum.  Following the first 3 
wk of diet administration, the rats received their first subcutaneous azoxymethane 
(AOM; 15 mg/kg body weight; Sigma, St. Louis, MO) injection, which is a colon-
specific carcinogen.  One week later, they received a second subcutaneous AOM 
injection.  The diets were provided for a total of 10 wk, after which the rats were killed 
using CO2 asphyxiation and cervical dislocation (Fig. 2).  Food intake and weight gain 
were recorded for each animal prior to the first AOM injection, 3 wk after the second 
AOM injection, and prior to killing. 
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 FIGURE 2 Experimental Timeline.  Diets were provided for 3 wk, after which the first 
AOM injection was administered.  After 1 wk, a second AOM injected was given.  After 
10 wk of the diets administration, the rats were terminated and samples were collected. 
 
 
 Experimental Diets. Semi-purified AIN-76A diets were provided containing 6% 
fiber from either cellulose, which was the control diet, or sorghum bran.  Three types of 
sorghum bran were used: white, containing a trivial amount of bioactive compounds; 
black, containing an intermediate amount of bioactive compounds; and brown, 
containing the highest amount of bioactive compounds (Fig. 3).  After the brans were 
analyzed for nutrient composition (Table 1), the diets were made equivalent in terms of 
macronutrient content (Table 2).  All diets contained corn oil as the source of dietary 
lipid.  The sorghum brans were prepared by decorticating the grain with a Prairie 
Regional Laboratory (PRL) Dehuller (52). 
 
 
FIGURE 3 Experimental Diet Groups.  Forty male Sprague-Dawley rats were split 
into four different diet groups with 10 rats in each group.   
 
Cellulose 
10 rats 
White Sorghum 
10 rats 
Brown Sorghum 
10 rats 
Black Sorghum 
10 rats 
40 Male  
Sprague Dawley Rats 
   
Start 
Feeding 
Diets 
 
3 weeks 
1st AOM  
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TABLE 1  Nutrient Analysis of Sorghum Brans 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 2  Composition of Experimental Diets   
 
Ingredients Control/ Cellulose White Sorghum Brown Sorghum Black Sorghum 
 g/100 g 
Diet Ingredients     
  DL-methionine1 0.34 0.34 0.34 0.34 
  Mineral mix, AIN-76 A1 3.91 3.91 3.91 3.91 
  Vitamin mix, AIN-76 A1 1.12 1.12 1.12 1.12 
  Choline bitartate1 0.22 0.22 0.22 0.22 
  Dextrose1 51.06 46.07 41.96 45.85 
  Casein1 22.35 20.80 20.50 20.67 
  Cellulose1 6.00 0.00 0.00 0.00 
  Sorghum bran2 0.00 13.49 18.21 13.22 
  Corn Oil1 15.00 14.05 13.75 14.67 
     
Macronutrient content  
  Carbohydrate3 51.06 49.19 47.79 48.96 
  Protein 22.35 22.35 22.35 22.35 
  Lipid 15.00 15.00 15.00 15.00 
  Fiber 6.00 6.00 6.00 6.00 
1Harlan Tekland, Madison, WI. 
 
2Cereal Quality Lab, College Station, TX. 
3Carbohydrate content varies because of the weight of ash and moisture in the sorghum bran fractions. 
 
 
 Sample Collection. After termination, the colon was removed and 2 cm were cut 
from the distal end of the colon (Fig. 4).  One half was fixed in 4% paraformaldehyde 
and used for apoptosis while the other half was fixed in 70% ethanol and used for 
proliferation assays.  The rest of the colon was cut longitudinally and rinsed with cold 
PBS.  One half was flattened and fixed with 70% ethanol to be used for aberrant crypt 
foci (ACF) enumeration.  The mucosal layer of the remaining half was scraped and a 
Ingredients White Sorghum Brown Sorghum Black Sorghum 
 % 
Protein 11.47 10.16 12.69 
Lipid 7.01 6.89 2.48 
Fiber 44.49 32.95 45.40 
Carbohydrate 23.04 32.00 23.51 
Ash 3.73 4.31 3.71 
Moisture 10.26 13.69 12.21 
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Apoptosis Proliferation 
ACF Enumeration 
Anitoxidant Enzyme Activity 
  Superoxide Dismutase 
  Catalase 
  Glutathione Peroxidase 
Proximal Colon Distal Colon 
GSH/GSSG 
(5-10 µg) 
2 cm 
small section (~5-10 	g) was snap frozen in liquid nitrogen and stored at -80°C for 
analysis of reduced/oxidized glutathione.  The rest of the scraped mucosa was 
homogenized with protein buffer (described in appendix), centrifuged, and aliquots were 
stored at -80°C to use for antioxidant enzyme assays (superoxide dismutase, catalase, 
and glutathione peroxidase) (38). 
 
 
 
 
 
 
 
 
FIGURE 4 Sample Collection.  Division of colon for data analysis. 
 
 
Aberrant Crypts. One half of the distal colon was flattened and fixed with 70% 
ethanol for 24 h, stained with methylene blue (0.5%) and used for aberrant crypt foci 
(ACF) enumeration.  After staining, the tissue was examined on a microscope at 40X 
and enumerated using the criteria of morphological characteristics previously described   
(28, 38).  Tissue was examined for aberrant crypt foci, total number of aberrant crypts 
within the foci, and high multiplicity aberrant crypt foci, which contain four or more 
aberrant crypts. 
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 Proliferation. Proliferation was assessed through detection of proliferating cell 
nuclear antigen (PCNA), which increases significantly during the S phase in mitosis 
because it is necessary for DNA replication and synthesis (61).  We used a monoclonal 
PC-10 antibody (Signet Lab, Dedham, MA) and a Vectastain ABC Elite Kit (Vector 
Lab, Burlingame, CA).  Negative controls were generated by using PBS in place of 
antibody during the assay.  For every sample, the number of PCNA positive cells and 
their location was recorded in 25 crypt columns and the proliferative index was 
calculated as a percent of the number of labeled cells, both light and dark, per number of 
cells in the crypt column (Fig. 5).  Proliferative zone was calculated as a percent of the 
highest labeled cell in the crypt per number of cells in the crypt column. 
 
   
FIGURE 5 Sample Images of Proliferation Measurements.  (A) Sample image of PCNA methodology 
for proliferation measurement. (B) Negative control generated by using PBS in place of antibody.  Images 
at 40X. 
 
 
A  B 
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 Apoptosis. Tissues fixed in paraformaldehyde were used to determine apoptosis 
with the TUNEL assay (Intergen, Norcross, GA).  Negative controls (not shown) were 
sections on each slide without TdT enzyme.  Positive controls used colon sections from 
AOM-injected irradiated rats killed at 9 h after injection, known as a biological control 
for apoptosis in the bottom of the crypts (62).  For every sample, apoptotic cells were 
identified by staining of diaminobenzidine tetrachloride (DAB) and appropriate 
morphological characteristics (Fig. 6).  The crypt height was recorded from both sides of 
25 crypt columns for each rat and the apoptotic index was calculated as the number of 
apoptotic cells/number of cells in the crypt column (62). 
 
   
FIGURE 6 Sample Images of Apoptosis Measurements.  (A) Sample image of TUNEL methodology 
for apoptosis measurement. (B) Positive control generated by using AOM-injected irradiated rats 
biologically known to have a high amount of apoptosis in the bottom of the crypt.  Images at 40X. 
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 Antioxidant Enzyme Activity. Cell lysates from the scraped mucosa of the colon 
were homogenized in protein buffer (described in appendix).  Afterward, they were 
centrifuged for 30 min at 15,000 x g and aliquots were stored at -80°C to be used for 
antioxidant enzyme assays.  Protein concentration was quantified using the Coomassie 
Plus Bradford assay kit (Pierce, Rockford, IL).  Superoxide dismutase (SOD) activity, 
both total and mitochondrial, was measured by ELISA following the manufacturers’ 
protocol (Cayman, Ann Arbor, MI).  Ten microliters of cell lysate sample diluted in 
protein buffer (1:100) was combined with xanthine oxidase, producing superoxide 
radicals, which were detected by the tetrazolium salt used in the reaction.  Potassium 
cyanide was added to another set of reactions to inhibit cytosolic (Cu/Zn) and 
extracellular (Fe) SOD, in order to detect the mitochondrial (Mn) SOD activity 
independently.  Absorbance was read at 450 nm and a standard curve was used to 
determine SOD activity in the samples.  Fifty percent dismutation of superoxide radical 
was defined as one unit of SOD activity (63).  Catalase (CAT) and glutathione 
peroxidase (GPx) were measured by following the kit protocols (Calbiochem, San 
Diego, CA).  In the CAT method, 20 µl of cell lysate sample diluted with protein buffer 
(1:40) was combined with methanol so that CAT could be measured based on its 
peroxidase activity with methanol in the presence of H2O2.  Purpald was the choromogen 
used to spectrophotometrically measure the formaldehyde produced from the reaction at 
540 nm.  One unit of CAT activity was defined as the amount of enzyme needed to form 
1.0 nmol of formaldehyde per min, which was obtained from the standard curve.  
Glutathione peroxidase (GPx) activity was an indirect measurement using 20 µl of cell 
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lysate sample diluted with sample buffer (1:20) coupled with the reaction of glutathione 
reductase, in which oxidized glutathione (GSSG) is converted back to reduced 
glutathione (GSH) using NADPH as the reducing equivalent.  Oxidation of NADPH to 
NADP+ is associated with a decrease in absorbance at 340 nm.  Conditions were such 
that GPx activity was rate limiting and therefore activity was directly proportional to 
decrease of A340 as a function of time.  All samples were run in triplicate along with 
standards provided on 96-well plates and read on a Spectra Max 250 microtiter plate 
reader (Molecular Devices, Sunnyvale, CA).  The enzyme activities were normalized to 
the amount of protein using the Coomassie Plus Bradford assay and expressed as units of 
activity/mg protein (38).  
 
 Reduced and Oxidized Glutathione. Colonocyte reduced and oxidized 
glutathione concentrations were assessed using an HPLC method of Jones et al (1998) 
with modifications.  Snap frozen tissue (~10 µg) was homogenized in 0.1 ml Solution A  
(1.05% L-serine, 0.1 mM sodium heparin, 2 mM bathophenanthroline disulfonate 
sodium salt, 11 mM iodoacetic acid, 80 mM boric acid, and 20 mM sodium tetraborate) 
plus 0.1 ml Solution B (1.2 mM perchloric acid and 200 mM boric acid).  After 
homogenization, an additional 0.1 ml Solution A and 0.1 ml Solution B were added to 
the homogenates.  The combined homogenates were centrifuged at 10,000 g for 1 min.  
The sample supernatant (150 µl) or 150 µl of GSH and GSSG standards (0, 50, 200, and 
500 µM each) were combined with 30 µl of 40 mM iodoacetic acid and 100 µl of 1 M 
KOH/1.6 M potassium tetraborate (pH ~9.0).  Subsequently, 150 µl of 75 mM dansyl 
 21 
chloride was added.  Both the samples and standards were vortexed and kept in dark at 
room temperature for 16 h, after which 250 µl chloroform was added.  The final mixture 
was centrifuged at 10,000 g for 1 min and 100 µl of the supernatant fluid (dansyl 
derivatives) was transferred to a micro-insert tube in a brown vial, with 25 µl injected 
into a 3-aminopropyl column (5 µm; 4.6 x 250 mm; Custom LC, Houston, TX).  
Reduced and oxidized glutathione were eluted from the column using Solvent A (0.8 M 
sodium acetate, 27% glacial acetic acid, and 63% methanol; pH 4.6) and Solvent B (80% 
Methanol) at the combined flow rate of 1.0 ml/min and the following gradient (0-10 min, 
20% Solvent A; 30-33 min, 80% Solvent A; 33.1-38 min, 20% Solvent A).  
Fluorescence detection (Waters 2475 Multi 
 Fluorescence Detector) was set at 590 nm 
excitation and 610 nm emission (0.0 to 7.5 min) to eliminate the appearance of amino 
acid peaks and at 335 nm excitation and 610 nm emission (7.5 to 38 min) for reduced 
and oxidized glutathione detection.  Gain of the detection was set at 100 (0 to 32.2 min) 
for reduced glutathione detection and at 1000 (32.2 to 38 min) for oxidized glutathione 
detection.  Reduced and oxidized glutathione were quantified based on peaks generated 
by standards (Sigma Chemicals, St. Louis, MO) using the MillenniumTM-32 Software 
and workstation (Fig. 7).  Concentrations were expressed relative to the amount of 
protein in the sample as measured by the Coomassie Plus Bradford assay (Pierce, 
Rockford, IL). 
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FIGURE 7 Sample Images of HPLC Analysis of Glutathione.  Example of HPLC 
standard (A) and sample (B) trace for glutathione (GSH and GSSG) measurements. 
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 Statistical Analysis. Data were analyzed using one-way analysis of variance 
(ANOVA) in SAS 9.1 (SAS Institute, Inc.) considering a p-value of <0.05 as significant.  
Outliers were removed if necessary and transformations were performed if normality 
was skewed.  A Wilcoxon-Rank Sums non-parametric test was used in SAS 9.1 to 
determine difference of tannin levels among diets.  Log regressions were run in SAS 9.1 
to identify the relationship of aberrant crypts, high multiplicity aberrant crypt foci, and 
apoptotic index with the antioxidant activity in the diet.  Finally, to account for slight 
differences that might have occurred in food intake, weight gain, and feed efficiency, we 
used these as covariates in the analysis of our end phenotype, ACF to see if they might 
have influenced the data.  These covariates did not alter the outcomes of those statistical 
analyses. 
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CHAPTER IV 
RESULTS 
 
 Food Intake, Weight Gain, and Feed Efficiency. In order to account for the 
potential of sorghum brans to affect food intake and body weight gain, we measured 
both variables over a 48 hr time period at wk 2, 7, and 10.  We also calculated feed 
efficiency, defined as body weight gain divided by food intake.  The food intake of black 
sorghum rats was depressed at wk 7 (relative to white sorghum rats) and wk 10 (relative 
to both white and brown sorghum rats), while cellulose rats were intermediate (Table 3, 
p < 0.02).  This slightly affected body weight gain and feed efficiency at wk 7, but 
apparent differences in those variables were resolved by wk 10 (see Table 5 and 6 in 
appendix).  Additionally, to account for slight differences that might have occurred in 
food intake, weight gain, and feed efficiency, we used these as covariates in the analyses 
of our end phenotype, ACF to see if they might have influenced the data.  These 
covariates did not alter the outcomes of those statistical analyses. 
 
TABLE 3 Food Intake Data1 
 
 
 
  
  
1Average 24-hr food intake data of rats over 48 hr time period at wk 2, 7, and 10.  
Data are means ± SEM for n=10 rats/diet.  Means without common letter differ (p < 
0.02). 
 Food Intake  
 Wk 2 Wk 7 Wk 10 
Diet g/24 h 
Cellulose 16.40 ± 0.410a 18.16 ± 0.518a,b 17.58 ± 0.410a,b 
White Sorghum 16.73 ± 0.410a 19.00 ± 0.518a 17.93 ± 0.410a 
Black Sorghum 16.14 ± 0.410a 17.01 ± 0.518b 16.59 ± 0.410b 
Brown Sorghum 16.91 ± 0.410a 17.65 ± 0.518a,b 17.84 ± 0.410a 
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 Antioxidant Enzyme Activity. The endogenous antioxidant defense system, 
composed of SOD, CAT, and GPx, is vital for regulation of the oxidative status of cells.  
We wanted to determine if the diet antioxidants affected the activity of these enzymes in 
the colon.  The black sorghum diet group had greater total SOD activity when compared 
to all other groups (Fig. 8, p < 0.04).  A similar trend was observed in mitochondrial 
SOD activity, yet there were no significant differences among the diet groups (Fig. 9).  
The white sorghum rats had increased CAT activity when compared to the cellulose rats 
(Fig. 10, p < 0.02), while the black and brown sorghum rat samples were intermediate.  
All sorghum rats, white (p < 0.03), black (p < 0.04) and brown (p < 0.001), had 
suppressed GPx activity relative to cellulose rats (Fig. 11). 
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FIGURE 8 Total Superoxide Dismutase Activity.  Rats provided a black sorghum diet 
had a greater level of total SOD activity when compared to rats in all other diet groups 
(p < 0.04).  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 9 Mitochondrial Superoxide Dismutase Activity.  No differences in 
mitochondrial SOD activity were seen among diet groups, yet the data showed a similar 
trend as seen in total SOD activity.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 10 Catalase Activity.  Rats provided a white sorghum diet had a greater level 
of CAT activity when compared to rats provided a cellulose diet (p < 0.02).  Black and 
brown sorghum groups were intermediate.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 11 Glutathione Peroxidase Activity.  All sorghum rats, white (p < 0.03), 
black (p < 0.04), and brown (p < 0.001) had a suppressed level of GPx activity when 
compared to rats provided a cellulose diet.  Data are means ± SEM for n=10 rats/diet. 
 
 
 
 
 Reduced and Oxidized Glutathione. The ratio of reduced (GSH) and oxidized 
(GSSG) glutathione is a good indicator of redox status (47).  The level of reduced 
glutathione (Fig. 12), oxidized glutathione (Fig. 13), and the ratio of the two (Fig. 14) 
were measured.  Although there were numerically greater concentrations of GSH and 
GSSG in the mucosa of all sorghum bran rats, there were no significant differences seen 
among the diet groups. 
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FIGURE 12 Reduced Glutathione Levels.  AOM-injected rats were measured for level 
of reduced glutathione (GSH).  No significant differences were observed.  Data are 
means ± SEM for n=10 rats/diet. 
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FIGURE 13 Oxidized Glutathione Levels.  AOM-injected rats were measured for 
level of oxidized glutathione (GSSG).  No significant differences were observed.  Data 
are means ± SEM for n=10 rats/diet. 
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FIGURE 14 Reduced/Oxidized Glutathione Ratio.  Ratio of GSH/GSSG was 
measured in AOM-injected rats.  No significant differences were observed.  Data are 
means ± SEM for n=10 rats/diet. 
 
 
 Proliferation. Rapid cell division can become harmful if unregulated in colon 
carcinogenesis, leading to tumor formation.  The distal colon (1 cm) was fixed in 70% 
ethanol and was embedded in paraffin in order to measure proliferation using PCNA as 
an indicator.  Crypt height measurements were combined for proliferation and apoptosis 
and no meaningful differences were found among groups.  The proliferative index was 
measured by the number intensely stained cells.  Total number of intensely stained cells 
was higher in cellulose rats when compared to those in the black (Fig. 15, p < 0.01) 
sorghum groups.   
 Proliferative index, calculated by number of intensely stained cells divided by 
crypt height, was higher in cellulose rats when compared to those in the black (Fig. 16, p 
< 0.01) sorghum groups.  Crypts were also separated into thirds in order to compare 
differences among each tertile.  Proliferative index of the middle tertile was higher in 
cellulose rats when compared to those in the black (Fig. 17, p < 0.009) sorghum rats.  
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Proliferative index in bottom tertile was higher in cellulose rats when compared to those 
in the black (Fig. 18, p < 0.014) sorghum rats.  The highest labeled cell in the crypt 
column is considered in order to determine proliferative zone.  Proliferative zone was 
higher in cellulose rats when compared to those in the black (Fig. 19, p < 0.04) sorghum 
rats.  There was no difference among diet groups in consideration of lightly stained cells. 
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FIGURE 15 Number of Intensely Stained Cells for Proliferation.  Absolute number of 
intensely stained cells per crypt was higher in cellulose rats when compared to those in the black 
(p < 0.01) sorghum rats.  White and brown sorghum rats were intermediate.  Data are means ± 
SEM for n=10 rats/diet. 
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FIGURE 16 Proliferative Index.  Proliferative index was measured as number of intensely 
labeled cells/crypt height (%). Proliferative index was higher in cellulose rats when compared to 
those in the black (p < 0.01) sorghum rats.  White and brown sorghum rats were intermediate.  
Data are means ± SEM for n=10 rats/diet. 
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FIGURE 17 Proliferative Index of Middle Tertile.  Proliferative index was measured as 
number of intensely labeled cells/total cells in tertile (%).  Proliferative index of the middle tertile 
was higher in cellulose rats when compared to those in the black (p < 0.009) sorghum rats.  White 
and brown sorghum rats were intermediate.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 18 Proliferative Index of Bottom Tertile.  Proliferative index was measured as 
number of intensely labeled cells/total cells in tertile (%). Proliferative index in bottom tertile was 
higher in cellulose rats when compared to those in the black (p < 0.014) sorghum rats.  White and 
brown sorghum rats were intermediate.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 19 Proliferative Zone.  Proliferative zone was measured as highest labeled cell/crypt 
height (%).  Proliferative zone was higher in cellulose rats when compared to those in the black 
(p < 0.04) sorghum rats.  White and brown sorghum rats were intermediate.  Data are means ± 
SEM for n=10 rats/diet. 
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 Apoptosis. Programmed cell death, apoptosis, is a means of eradicating damaged 
cells, which otherwise could form tumors.  The distal colon (1 cm) was fixed in 4% 
paraformaldehyde and was embedded in paraffin in order to measure apoptosis using the 
TUNEL assay.  The total number of apoptotic cells was identified based on staining and 
morphological changes.  Apoptotic index was calculated as total number of apoptotic 
cells per total cells in crypt height.  The crypt was split into tertiles and the apoptotic 
index was recorded for each.   
 There were no differences in crypt height among different diet groups.  The total 
number of apoptotic cells (Fig. 20, p < 0.027) as well as overall apoptotic index (Fig. 21, 
p < 0.03) was higher in brown sorghum rats when compared to cellulose rats.  The 
apoptotic index in the top tertile was elevated in both black (p < 0.0066) and brown  
(p < 0.034) sorghum rats (Fig. 22).  The apoptotic index in the middle tertile was higher 
in brown sorghum rats when compared to cellulose rats (Fig. 23, p < 0.029).  Apoptotic 
index in the bottom tertile was not significant due to the low number of apoptotic cells in 
the bottom of the crypt. 
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FIGURE 20 Number of Apoptotic Cells.  The absolute number of apoptotic cells was recorded 
in colonic crypts.  Brown sorghum rats had a higher number (p < 0.027) of apoptotic cells per 
crypt than did cellulose rats.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 21 Apoptotic Index.  The apoptotic index was calculated as total number of apoptotic 
cells in a crypt column/crypt column cell number.  Brown sorghum rats had a higher apoptotic 
index (p < 0.03) than did cellulose rats.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 22 Apoptotic Index of Top Tertile.  The apoptotic index was calculated as total 
number of apoptotic cells in a crypt column/crypt column cell number in each tertile of the crypt.  
Both black (p < 0.0066) and brown (p < 0.034) sorghum rats had a higher apoptotic index than 
did cellulose rats.   Data are means ± SEM for n=10 rats/diet. 
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FIGURE 23 Apoptotic Index of Middle Tertile.  The apoptotic index was calculated as total 
number of apoptotic cells in a crypt column/crypt column cell number in each tertile of the crypt.  
Brown sorghum rats had higher apoptotic index (p < 0.029) than did cellulose rats.   Data are 
means ± SEM for n=10 rats/diet. 
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 Aberrant Crypts. Aberrant crypts were measured in order to establish the overall 
effect of the diet groups as a protective measure against colon carcinogenesis.  The total 
number of aberrant crypts was significantly lower in rats consuming black (p < 0.05) and 
brown (p < 0.0017) sorghum diets when compared to those consuming the cellulose diet; 
the brown sorghum group (p < 0.03) was also lower when compared to white sorghum 
group (Fig. 24).  The number of aberrant crypt foci was lower in rats consuming brown 
sorghum as compared to those consuming cellulose (Fig. 25, p < 0.005).  High 
multiplicity aberrant crypt foci showed the same trend as was seen in total aberrant crypt 
data in which rats consuming black (p < 0.03) and brown (p < 0.0002) sorghum diets had 
fewer numbers when compared to those consuming the cellulose diet.  Brown sorghum 
rats (p < 0.001) also showed fewer HMACF than white sorghum rats (Fig. 26). 
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FIGURE 24 Total Number of Aberrant Crypts.  AOM-injected rats were measured 
for total number of aberrant crypts (AC).  Total AC were lower in animals from the 
brown (p < 0.0017) and black (p < 0.05) sorghum group as compared to those in the 
cellulose group.  Animals in brown group had less total AC as compared to white 
sorghum animals (p < 0.03).  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 25 Total Number of Aberrant Crypt Foci.  AOM-injected rats were 
measured for total number of aberrant crypt foci (ACF).  Total ACF were lower in 
animals from the brown (p < 0.005) sorghum group as compared to those in the cellulose 
group.  Data are means ± SEM for n=10 rats/diet. 
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FIGURE 26 High Multiplicity Aberrant Crypt Foci.  High multiplicity aberrant crypt 
foci (HMACF) were lower in AOM-injected rats from the brown (p < 0.0002) and black 
(p < 0.03) sorghum groups as compared to those in the cellulose group.  Animals in the 
brown group had fewer HMACF compared to white sorghum animals (p < 0.01).  Data 
are means ± SEM for n=10 rats/diet. 
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 Regressions Using Diet Antioxidant Activity. In order to compare the 
antioxidant potential of the experimental diets, we measured the content of phenols and 
tannins and the actual antioxidant activity (ABTS) of the diets themselves (Table 4).  
When we compared antioxidant activity of the diets with the total number of aberrant 
crypts (Fig. 27, p < 0.02) and high multiplicity aberrant crypt foci (Fig. 28, p < 0.04) in 
the animals, we observed an exponential decrease in aberrant crypts as a function of 
increasing antioxidant activity. We also compared the diet antioxidant activity with 
apoptotic index.  While there was a tendency for apoptotic index to be higher in rats 
consuming diets with higher antioxidant activity, this relationship was not statistically 
significant (see Fig. 32 in appendix, p < 0.07).  
 
 
TABLE 4  Diet Compound Analyses1,4 
 
Diet Phenol 
 
Tannin2 
 
ABTS 
 
 mg GAE/g3 mg CE/g3 µmol TE3 
Cellulose 0.281 ± 0.021a 0.072 ± 0.042a 7.893 ± 0.144 a 
White Sorghum 0.776± 0.035 b 0.069 ± 0.041 a 14.88± 0.271b 
Black Sorghum 4.986± 0.092 c ND 85.61 ± 1.558 c 
Brown Sorghum 14.15 ± 0.148 d 19.03 ± 1.304 b 226.4± 4.121 d 
  
1
 Data are means ± SEM for n=10 /diet.  Means in columns with superscripts 
without a common letter differ, P < 0.001 unless denoted otherwise.  Measured by 
one-way ANOVA test. 
  
2 Mean in columns without a common letter differ, P < 0.002.  Measured by a Wilcoxon 
rank-sums non-parametric test. 
  
3GAE, gallic acid equivalents; CE, catechin equivalents; TE, trolox equivalents. 
  
4Samples were analyzed by the Cereal Quality Lab at Texas A&M University. 
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FIGURE 27 Total Number of Aberrant Crypts vs. Antioxidant Activity.  Four 
experimental diets were fed to 40 AOM-injected rats (n=10/diet).  The antioxidant 
activity of the diets was measured by 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic 
acid (ABTS) method.  Aberrant crypts were counted from the distal colon of all animals.  
A trend was observed in which the total number of aberrant crypts decreased as the 
antioxidant activity of the diet increased (p < 0.021). 
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FIGURE 28 High Multiplicity Aberrant Crypt Foci vs. Antioxidant Activity.  Four 
experimental diets were fed to 40 AOM-injected rats (n=10/diet).  The antioxidant activity of the 
diets was measured by 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS) method.  
HMACF were counted from the distal colon of all animals.  A trend was observed in which the 
total number of HMACF decreased as the antioxidant activity of the diet increased (p < 0.04). 
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CHAPTER V 
DISCUSSION 
 
 As stated, we chose to study sorghum in a colon cancer model due to previous 
observations seen in which certain populations had decreased incidence of esophageal 
cancers, and these same populations have been identified with lower risk of colon cancer 
(9, 13).  It was postulated that a dietary fiber effect alone accounted for lowered colon 
cancer risk; however, other trials have shown inconsistent data based on that hypothesis 
(30).  It is known that grains, in their entirety, contain other components besides dietary 
fiber and these also could be contributing to the previous observations.  Sorghum in 
particular, varying by type, contains certain bioactive compounds (phenolic acids, 
anthocyanidins, and tannins) whose actions in vivo need to be characterized in order to 
clear up our understanding of whole grain chemoprotection in colon carcinogenesis. 
 In the past, tannins were shown to bind proteins and decrease protein digestibility 
and feed efficiency in animals (64, 65).  However, we did not observe an effect on 
weight gain, food intake, or feed efficiency in the tannin (brown) sorghum rats.  We saw 
a slight decrease in food intake in the black sorghum rats at the end of the study, though 
this did not affect weight gain or feed efficiency.   
 We did observe a sorghum effect with respect to the preneoplastic lesions of 
colon cancer, ACF.  Both the black and brown sorghum rats had significantly fewer total 
aberrant crypts and high multiplicity aberrant crypt foci when compared to cellulose rats.  
Rooney et al (7) previously studied the effect of white and brown sorghum bran on 
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colonic physiology in male Sprague-Dawley rats.  They found that both sorghums act as 
great bulking agents.  In relation to control, both white and brown sorghum brans did not 
cause a decrease in colonic pH, which is attributed with enhanced carcinogenesis (66, 
67).  They postulated that brown sorghum bran could have a positive influence on the 
colon.  This was confirmed by our study in which rats consuming brown sorghum bran 
had the lowest number of ACF. 
 The black and the brown sorghum brans contain high amounts of 3-
deoxyanthocyanidins and tannins, respectively, and they are the two diets measured with 
the highest antioxidant activity by ABTS.  We further analyzed this observation by 
running log regressions of diet antioxidant activity with total aberrant crypt and high 
multiplicity aberrant crypt data.  Both regressions show a strong inverse relationship and 
suggest that the ability of these diets to suppress colon carcinogenesis could be linked to 
their high antioxidant potential and/or the other biological activities of the compounds 
that generate the antioxidant activity. 
 Significant alterations to cell cycle response were also observed in both the black 
and brown sorghum rats.  In the case of proliferation, the black sorghum rats had fewer 
absolute numbers of proliferating cells and a lower proliferative zone, and proliferative 
index overall and in the middle and bottom tertiles.  Shih et al (68) tested 
chemoprotective properties of 3-deoxyanthocyanidins, luteolinidin and apigenidin, the 
two main anthocyanidins in black sorghum.  These compounds were able to reduce 
viability of human cancer cell lines (leukemia HL-60 and hepatoma HepG2) and were 
able to achieve this more effectively than their anthocyanidin counterparts (cyanidin and 
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pelargonidin).  This suggests that inhibition of cancer cell viability by 3-
deoxyanthocyanidins may be enhanced by dehydroxylation at the C-3 position on the 
compounds.  Luteolinidin was more effective than apigenidin at inhibition of cancer cell 
growth. 
 Hou et al (69) found that certain anthocyanidins (delphinidin, petunidin, and 
cyanidin, Fig. 29) contributed to the inhibition of tumorigenesis via the blocking of 
MAPK pathway activation and AP-1 activation in JB6 mouse cells.  It was hypothesized 
that these compounds were able to block AP-1 activation due to the ortho-
dihydroxyphenyl structure on the B ring because the three compounds that caused 
inhibition are the only compounds that contain this particular structure. 
 
     
  
 
FIGURE 29 Structure of Anthocyanidins and 3-Deoxyanthocyanidins.  (A)Stucture 
of common anthocyanidins.  The ortho-dihydroxyphenyl structure on the B ring is 
hypothesized to be involved in AP-1 inactivation via structure-activity relationships. (B) 
Stucture of common 3-deoxyanthocyanidins in black sorghum.  Luteolinidin contains the 
ortho-dihydroxyphenyl structure discussed in Hou’s paper.  
 
 
  
A B 
Name    R1  R2  R3 
Apigenidin  H  OH OH 
Luteolinidin  OH OH OH 
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Cyanidin  OH  H  
Delphidin OH  OH  
Petunidin OCH3  OH 
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 Furthermore, Hou et al (69) found that AP-1 activity was also blocked by SOD 
activity, but not by CAT.  It appears that the superoxide anion is involved in the 
activation of AP-1 activity.  Hou et al (69) found a synergistic affect of AP-1 
inactivation when SOD activity and anthocyanidins were combined.  Interestingly, we 
also saw an increased amount of SOD activity in the colons of rats eating the black 
sorghum diet, which occurred in conjunction with a decreased amount of proliferation in 
these animals.  Black sorghums also contain a high amount of 3-deoxyanthocyanidin 
luteolinidin, which has the same structure as anthocyanidins above, but without a 
hydroxyl group on the third carbon of the C ring (Fig. 29).  Luteolinidin maintains the 
ortho-dihydroxyphenyl structure.  Perhaps this may contribute to its greater cytotoxicity 
against cancer cells over apigenidin and conceivably our anticarcinogenic observations 
are also due to the structure-activity relationship reported by Hou et al (69). 
 When compared to cellulose, brown sorghum rats demonstrated an elevated 
amount of apoptotic cells and a higher apoptotic index, contributing to their ability to 
suppress tumorigenesis.  Black sorghum rats showed higher apoptotic index compared to 
cellulose rats in the top tertile, but not overall.  Chang et al (36) saw among 
measurements of proliferation, differentiation, and apoptosis, that apoptosis was the best 
indicator of tumorogenesis.  Though black sorghum rats showed a significant 
suppression of proliferation, the enhanced apoptotic index in brown sorghum rats was a 
better indicator of cancer prevention, confirmed by the fact that they had the lowest 
amount of aberrant crypts. 
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 Previous studies have shown the ability of condensed tannins to induce apoptosis 
in human colon cancer cells (70, 71).  Al-Ayyoubi et al (72) showed an induction of 
tumor-suppressor gene p53 in HCT-116 p53 +/+ colon cancer cells with treatment of 
gallotannin and an induction of apoptosis in HCT-116 p53 -/- cells.  In addition, 
condensed tannins from grape seeds induced apoptosis through inhibition of anti-
apoptotic PI3-K activity in CaCo2 cells (73).  The condensed tannins found in our brown 
sorghum diet could be inducing apoptosis via similar pathways in order to prevent 
tumorogenesis. 
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FIGURE 30 Antioxidant Enzyme Schemes.  Reaction scheme of antioxidant enzymes and 
glutathione. SOD, superoxide dismutase; CAT, catalase; A, acid; H-S, reducing substrate; GPx, 
glutathione peroxidase; GR, glutathione reductase. 
 
 
 
 
 In order to see how a high load of exogenous antioxidants might affect the 
endogenous antioxidant environment (Fig. 30), we measured three antioxidant enzymes 
and a redox indicator, glutathione.  SOD activity was elevated in black sorghum rats 
when compared to cellulose rats.  CAT activity was elevated in white sorghum rats when 
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compared to cellulose rats.  GPx activity was suppressed in all sorghum rats when 
compared to cellulose rats.  However, no significant changes were seen in actual redox 
environment as indicated by measurements of reduced and oxidized glutathione. 
 As discussed earlier, SOD has been shown to help inhibit AP-1 activity in a 
synergistic manner with certain anthocyanidins (69).  Given that luteolinidin, a main 3-
deoxyanthocyanidin in black sorghum, has a comparable structure to these 
anthocyanidins, this gives rise to a potential mechanism of action for the black sorghum 
diet.  The 3-deoxyanthocyanidin could work in conjunction with SOD to inihibit AP-1 
activity, proliferation, and carcinogenesis. 
 Recently, CAT has been attributed with a third, previously unrecognized oxidase 
activity (74).  In low concentrations of H2O2, oxygen-dependent CAT oxidase activity 
will catalyze the oxidation of
 
reducing substrates (75).  However, an incomplete reaction 
could result in the formation of radical intermediates and superoxide anion (see Fig. 30).  
Vetranon et al (74) showed that phenolic acids, ferulic and vanillic acids, were 
competitive inhibitors for substrate 10-acetyl-3,7 dihydroxyphenoxazine used in their 
characterization of the catalase oxidase activity.  Due to the speculation that catalase 
oxidase could be important in activating carcinogens, such as benzidine, to form further 
carcinogenic derivatives, they postulated that this competitive inhibition by phenols 
could aid in anti-cancer activity.  
 Perhaps the measured peroxidative activity of CAT in our study was enhanced in 
the white sorghum (contains phenolic acids) rats because the phenolic acids were 
competitive inhibitors of the oxidase function of the enzyme.  The phenolic acids 
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increased the Km of the oxidase activity, making it less effective and H a more 
competitive substrate to enhance the other functions of CAT, which we measured. 
 Higher levels of GPx activity were found in colonic tumor tissue when compared 
with normal tissue because the tumor was exposed to more oxidative stress and there 
was a need to enhance an antioxidant defense against this (44).  The suppression of GPx 
in all sorghum rats when compared to cellulose suggests an ability of the cells to handle 
a higher amount of oxidative injury that occurred with tumor initiation.  Perhaps this was 
due to the high amount of exogenous antioxidants present in the colon that were 
provided by the diets.  To a certain extent, this protection against potential oxidative 
injury enabled the tissue to form fewer aberrant crypts in the sorghum rats. 
 In all of this, no significant overall change in redox status was seen in the tissue 
as measured by reduced and oxidized glutathione at the end of the study.  This suggests 
that while there are shifts in antioxidant enzyme activities among diets, a general redox 
status was maintained in the cells.  So while the colon was affected by changes in 
antioxidant enzyme levels, perhaps the mechanisms by which proliferation was inhibited 
in black sorghum rats and apoptosis was induced in brown sorghum rats were not ROS-
dependent. 
 Our end phenotype, ACF, showed a significant sorghum effect in the ability to 
suppress colon carcinogenesis.  The white sorghum rats, though not significantly 
different from celllose, had a numerically lower amount of ACF when compared to 
cellulose.  This numerical reduction could be attributed to the elevation of peroxidatic 
CAT activity in the quenching of H2O2 and the potential inhibition of CAT oxidase 
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activity.  The black sorghum rats had fewer ACF than cellulose.  This could be due to 
the synergistic effect of enhanced SOD activity and 3-deoxyanthocyanidins on the 
inhibition of proliferation via AP-1 suppression.  Finally, the brown sorghum rats had 
fewer ACF than all other diets.  These rats had the highest apoptotic index, potentially 
due to the condensed tannins, which have previously been shown to induce apoptosis in 
human colon cancer cell lines (70, 71).  In addition to these observations, all sorghum 
diets suppressed GPx activity, displaying an ability of the exogeneous antioxidant load 
to down-regulate need for endogeneous antioxidant enzymes.  This suggests that 
colonocytes from rats consuming sorghum bran were able to handle the oxidative injury 
at the time of the carcinogen injections, due in part to the high antioxidant activities of 
the diets. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
 Summary. Sorghum had a significant effect on the suppression of colon 
carcinogenesis in rats as measured by a reduction in ACF being formed.  The 
suppression of ACF in rats consuming varying types of sorghum occurred in part 
through their differential actions on endogenous antioxidant enzymes, proliferation, and 
apoptosis.  White sorghum was effective at enhancing CAT activity while black 
sorghum enhanced SOD activity.  All sorghum diets suppressed GPx activity.  In 
addition, black sorghum effectively inhibited proliferation and brown sorghum enhanced 
apoptosis.  These varying effects of sorghum diets on endogenous enzymes and cell 
cycle responses suggest that the different bioactive compounds present in the diets could 
be the causative agents.  More research is needed to determine the specific effect of 
these compounds in their potential ability to suppress colon carcinogenesis. 
 
 Conclusions. Bioactive compounds that are present in sorghum have been 
previously shown to inhibit carcinogenesis (56, 68-73).  Our findings also demonstrate 
the ability of sorghum bran to suppress colon carcinogenesis.  Due to the differential 
actions of the sorghum brans on antioxidant enzymes and cell cycle responses, we 
believe that this suppression is in part due to the bioactive compounds present in the bran 
of these grains.  These bioactive compounds could be functioning via mechanisms 
presented by other studies (Fig. 31).  Future research with sorghum is merited in regards 
 49 

  	
 
   
     
  
	
  
  
! !  
 
  
" 

  
#$$%#&' 
	

(
 
	

(
 
	

)$ 
* + , - 
 .     
/ 01 

23	
(4(
 
23	
(4(
 
2O2˙- + 2H+       H2O2 + O2       
 5 
 

23	
(4(
 
to colon cancer prevention given that the specific mechanisms of action of these 
bioactive compounds in sorghum have yet to be identified.  To sum up, sorghum has the 
capability to suppress colon carcinogenesis and the bioactive compounds in the grain 
should be considered further as potential chemoprotective agents. 
 
 
 
  
 
 
 
 
 
FIGURE 31 Potential Mechanisms Involved in Black and Brown Sorghum Effects.  Engelbrecht 
(73) has shown the ability of condensed tannins to induce apoptosis via the reduction of both the 
catalytic (p110) and regulatory (p85) subunits of PI3K, suppressing its activity.  PI3K phosphorylates 
PIP2, generating PIP3 which activates AKT, a promoter of cell survival.  Condensed tannins were also 
able to the attenuate activation of AKT.  The condensed tannin was also able to decrease PTEN 
phosphorylation, making it more active as a negative regulator of the PI3K/AKT signaling pathway.  
Perhaps the condensed tannins present in brown sorghum diet were able to induce apoptosis through 
inhibition of PI3K through similar pathways as observed by Engelbrecht.  Hou (69) has shown the 
ability of anthocyanidins to inhibit transcription factor, AP-1, an important transcription factor in 
proliferation that is inducible by tumor promoters.  Anthocyanidins were also able to inhibit 
MAPKinases c-Jun N-terminal kinase (JNK) and extracellular signal-regulated protein kinase (ERK).  
He postulated that this may be due to the ortho-dihydroxyphenyl structure on the B-ring of the 
anthocyanidins, a structure also present on luteolinidin, the main 3-deoxyanthocyanidin in black 
sorghum bran.  Interestingly, he found a synergistic effect of anthocyanidins and SOD activity on the 
inactivation of AP-1.  We also found increased SOD activity in black sorghum rats.  Perhaps the 
suppression of proliferation was due to mechanisms similar to those described by Hou in which 
anthocyanidins are able to inhibit AP-1 activation in part to scavenging of superoxide radicals and in 
part to blocking MAPK pathways. 
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 Future Research. This was a preliminary study designed to make general 
observations about the effects of sorghum brans, and possibly the compounds in the 
bran, on colon carcinogenesis.  We saw significant effects of this grain in a colon cancer 
model, but further research is needed. 
 Future research is needed in order to study the mechanisms of action of our 
bioactive compounds of interest (luteolinidin, apigenidin, tannins).  A study is needed to 
measure the activation of transcription factor AP-1 in response to 3-
deoxyanthocyanidins present in sorghum, luteolinidin and apigenidin.  It would also be 
beneficial to measure levels of tumor-suppressor gene p53 or anti-apoptotic PI3K levels 
in response to condensed tannins.  Perhaps cell culture models should be employed first, 
followed by animal studies using diets supplemented with the compounds themselves. 
 It would also be beneficial to study actual uptake and bioavailability of these 
bioactive compounds in the colon.  If the compounds are tightly bound to fiber, they 
could make it to the colon intact and have a direct effect on the luminal environment or 
the coloncytes themselves.  Gu et al recently did an excellent job studying the uptake of 
sorghum phenols in female Sprague-Dawley rats (76).  In the future, we should model 
this study with our actual compounds of interest in the diet to determine if they act alone, 
or if it is indeed a synergistic effect with the rest of the sorghum bran. 
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APPENDIX A 
EXPERIMENTAL PROTOCOLS 
Kill Day Set-up & Checklist 
 
 
General 
• Tape bench papers on lab benches and line with extra bench papers; replace 
bench papers as necessary. 
• Put up instruction/reminder sheets and Rat Kill List at every station. 
• Put out gloves of all sizes, boxes of Kim wipes, sufficient napkins, and sharpies 
at each station. 
• Make sure liver Rnase-free utensils and supplies are properly “Zapped” the day 
before kill. 
• Label timers, ACF tub covers, homogenization tubes and pestles 
• Tape 2 - 3 biohazard bags on benches where needed 
• Make solutions, ensure plenty of reserves; chill those that require chilling. 
 RNase-free & regular 1X PBS 
 4% PFA  
 50% & 70% EtOH 
 Heparin Soln. 
• Complete rat’s 48-hr diet intakes 
• Move homogenization buffer from freezer to fridge 
• Put up rat kill lists and instruction sheets 
• Inform Aleta to prepare cages, covers and a cart for rats to be moved up to 2nd 
floor 
• Tapes & Dispenser 
• Assemble rat transport cages 
 
Kill Station 
• Check CO2 tank, chamber, weights, cover cloth 
• Black trash bags for rat bodies 
• PBS in squirt bottle-RNAse Free 
• Surgical tools 
1. Straight scissors (black handle) 
2. Bent large scissors 
3. Forceps-(1) bent, (1) straight 
4. Small blunt tip scissors 
• Extra bench papers 
• Weigh dishes, 1 big, 1 medium, 2 small labeled with rat # 
• Extra weigh dishes all sizes 
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• Rat packs 
• Gauze – lots 
• Ice bucket for PFA cubes 
• 1 ml pipette with tips 
• Instruction sheet 
• Liquid Nitrogen Container 
• Sharps Container 
• Sharpie 
• Gloves 
 
 
ACF Station 
 
• Big weigh dishes labeled with rat # (for holding colon) 
• PBS in squirt bottle (1) 
• 600mL glass beaker (1) covered w/foil 
• Ice bucket (to hold PBS beaker) (1) 
• 10cc syringe attached with RNase-free round-tip needle (4)  
• Scapels & blades (4) 
• Forceps (1 straight, 1 bent) 
• Small blunt-tip scissors (1) 
• Medium weigh boats for colon 
• Labeled Whatman filter papers (in ziplock bag) 
• ACF tupperwares and glass plates (2) 
• Boat with 70% ethanol 
• 70% EtOH 
• “ART XLP 200”, P200 pipette (1) 
• Biohazard bag 
• Record sheet for any observations 
 
 
Cassetting Station 
 
• Ice tubs for holding small specimen cups (1) 
• Labeled timers with rat # (8) 
• Labeled big specimen cup with lid for holding cassettes fixed in 70% EtOH (1) 
• Labeled cassettes with sponges (2/rat) 
• Forceps (1 straight, 1 bent) 
• Small scissors (1) 
• 1X PBS in squirt bottle 
• Labeled rat #, date and fixation small specimen cups with lids (wrap ones) for 
holding cassettes fixed in 4% PFA (8) 
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• Large weigh boats labeled with rat # 
• Cold 4% PFA 
• 70% EtOH 
• Igloo coolers for holding ice (2) 
• Record sheet for PFA fixation EtOH changes 
 
 
Mucosal Scrapping and Homogenization Stations 
 
• Ice buckets for storing homogenization buffer and eppetubes 
• Homogenization buffer 
• Denaturation Buffer 
• 2ml RNAse free eppitube /rat 
• Ice box for holding glass 
• Piggyback racks for holding eppitubes  
• Square ice box for holding square glass plate 
• Microscope slides 
• Curved forcep (1) 
• Water in squirt bottle (from bottled sterile water) 
• 1X PBS in squirt bottle 
• “ART XLP 200”, “ART 1000E”, and “10 Reach” pipette tips 
• P1000 pipette (2), P200 pipette (1), and P10 pipette (1) 
• Small specimen cups for rinsing (2) 
• 2-mL homogenization tubes and pestles (labeled and in ziplock bags) 2/rat 
• Pre-weighed tubes for GSH/GSSH 
• Homogenization instruction sheet 
• Balance 
• Data sheet 
 
 
Protein Isolation Station 
 
• Centrifuge machine 
• Timer labeled (4) 
• 1cc Luer-Lok syringe with 27G 1¼  needle (8+) 
• Sharps container 
• Labeled 0.65mL  
• 2 mL eppetubes for protein (2) (1 white to centrifuge, 1 yellow to transfer 
supernatant) 
• Ice chest to hold eppitubes (2) 
• Piggyback rack 
• P200 and P1000 pipettes and pipette tips 
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• Calculator 
• Instruction sheet 
• Remarks record sheet and sharpie 
• Gloves 
 
Liver Station 
 
• 3 ice buckets 
• Zapped glass plate (4) 
• 1.8 ml tubes (2/rat) 
• Labeled RNA later bottle – 5 ml (1/rat) 
• Chopping tools (4) 
• Zapped scissors 
• NaCl and heparin solution (300 ml/ rat) 
• Beaker 250 ml (covered w/foil) 
• 10 ml syringe(2) and needles (1/rat) 
• Cryobags for extra liver (1/rat) 
• Kimwipes 
• Gloves 
• Catch Tub for liver perfusion 
• Tub of Soapy Water 
• Large liquid nitrogen container 
• Spatulas –Spoon shaped (2), Straight (2) 
• Pen, Sharpie 
• Ziplock bag 
• Instruction Sheet 
 
Blood Station 
 
• 1 ice bucket next to centrifuge 
• 0.6 and 0.3 ml heparin tube 
• 1 ml cryotube 
• Container for liquid N2 
• Rotator and ice in cold room 
• Centrifuge at 4 °C 
• Balance 
• Syringe 2 ml/needle 
• Pipette heparinated 
• 3 Marma tubes 
• 1 marma – Ac tube 
• Balancing tubes for centrifuge 
• Recording Sheet 
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• Sharpie Pen 
 
Morning of Kill 
 
1. Take protease inhibitor and protein buffer (previously aliquoted) out of freezer to 
thaw.  
2. Scoop lots of ice and fill necessary tubs, boxes, and mug; store the remaining in 
ice igloos. 
3. Take out heparin solution keep on ice  
4. Remove denaturation solution from fridge; keep in ice. 
5. Turn on both centrifuges at appropriate temp. 
6. Add protease inhibitor to buffer and keep in ice. 
7. Prepare and move rats from basement to kill station; keep food in cages. 
8. Assemble specimen cups for cassetting – put in tub filled with ice, fill with ice-
cold 4% PFA, store in ice chest. 
9. Fill ACF tubs and EtOH fixation specimen cups with 70% EtOH. 
 
 
After Kill 
 
1. Store samples in appropriate place 
2. Clean up 
3. Autoclave biohazard trash and bring to dumpster 
4. Bring rat bodies to freezer in basement diet mixing room 
5. Wash tools and glassware; put to dry in oven 
6. Solution changes 
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Aberrant Crypt Foci Enumeration Protocol 
(Cindy Warren, 2001. Modifications by Kim Paulhill, 8/2007) 
Supplies: 
  Methelyne blue in clear specimen cup 
  PBS in clear specimen cup 
  70% Ethanol in clear specimen cup 
  Rubber gloves 
  Long stem cotton swabs 
  Labeled tissue samples in clear specimen cups 
  Clear grid (with ½ cm squares) 
  ACF score sheets 
  Flash Drive 
  Paper towels 
  Clip board 
Procedure:   
1. Place all supplies in small cooler with waffle lab bench paper in the bottom of 
cooler in case of spillage. 
 
2. In the microscope room, turn on the four switches and  prepare to use the 
microscope (computer, scope, TV screen, grey box).   
  
3. Stain the tissue by dipping in the methylene blue for 10-45 seconds.  If too dark 
dip it back into 70% ethanol.  
  
4. Place on plastic grid taped onto microscope stage, beneath lens, 10X 
magnification.  Take care not to touch the lens.   
 
5. Note rat ID number, length of colon, date, etc. on the score sheet.   
 
6. Starting on the distal end (this end doesn’t have tissue architecture with ridges).  
Go slowly through each box, examining the tissue.   
 
7. Note any ACF, both position and multiplicity. 
i. Normal crypts are oval or round and a lighter blue stain.   
ii. ACF are darker and have swirl-like appearance.   
iii. Many of the ACF have increased size, thicker epithelial lining, and darker 
staining luminal openings.   
iv. Compare the ACF to the surrounding tissue.   
v. Hyperproliferative crypts are not as distorted as the ACF. 
vi. ACF have a larger white, distorted zone in the luminal opening.   
vii. Peyer’s patches are lymphatic tissue; look like big cloudy spots.  
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8. Make sure that tissue does not dry out—using cotton swap, moisten tissue 
periodically with PBS.  It should remain shiny. 
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Buffer Selection- Protein Homogenization 
 
 
Three rats were killed to practice antioxidant assay in colon mucosa.  Two different 
kinds of buffers were used to homogenize the protein: Dr. Wu’s modified buffer and a 
modified version of that buffer.  The buffer was modified by Jairam, Laurie and Dr. 
Turner, so the samples can be used for Western blot assays.  Dr. Wu’s modified buffer 
seemed to offer better results for antioxidant enzyme quantification than the modified 
homogenization buffer.  Apparently the protein recovery is also higher with Dr. Wu’s 
modified buffer.  However, this buffer was used for the actual experiment.  10 mL of 
buffer were prepared for each killing day (8 rats).  
 
Dr. Wu’s Homogenization Buffer 
 
1. Preparation of Stock solutions 
 
Stock 1.  50mM K2HPO4:  Dissolve 4.35g of K2HPO4 in 500ml of deionized 
H2O 
 
Stock 2.  50mM KH2PO4:  Dissolve 3.4g of KH2PO4 in 500ml of deionized H2O 
(use 1L bottle) 
 
Stock 3.  Prepare 50mM Potassium Phosphate buffer (pH 7.2) 
Add 50mM K2HPO4 (stock 1) to 50mM KH2PO4 (stock 2) until pH is 7.2 
Stock 4.  Prepare 250mM Sucrose/1mM EDTA solution by dissolving 42.8g of 
sucrose and 186mg of disodium EDTA in 500ml of potassium phosphate buffer 
(stock 3).  pH again to 7.2 (use KOH or HCl) 
 
2. Preparation of homogenization buffer (adapted from Dr. Wu’s assay for enzyme 
extraction).  250mM sucrose/1mM EDTA/1mM DTT in 50mM potassium 
phosphate buffer:   
 
5ml   250mM sucrose/1mM EDTA solution (stock 4) 
200µl    protease inhibitor cocktail 
5µl    Triton X-100 (0.1%) 
5µl    1M DTT solution (made fresh) 
0.3858 mg   DTT in 2.5mL Phosphate Buffer 
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Dr. Wu’s Modified Homogenization Buffer 
(Modification suggested by Jairam, Laurie and Dr. Turner) 
 
 
250 mM sucrose/1mM EDTA/1mM DTT in 50 mM potassium phosphate buffer.  
Modification consists of final concentration of 0.1% triton rather than 0.0001% and use 
of sodium orthovanadate.  
 
 
Preparation of Dr. Wu’s Modified Homogenization Buffer 
1.  Preparation of Stock solutions 
 
Stock 1.  50mM K2HPO4:  Dissolve 4.35g of K2HPO4 in 500ml of deionized 
H2O 
 
Stock 2.  50mM KH2PO4:  Dissolve 3.4g of KH2PO4 in 500ml of deionized H2O 
(use 1L bottle) 
 
Stock 3.  Prepare 50mM Potassium Phosphate buffer (pH 7.2) 
Add 50mM K2HPO4 (stock 1) to 50mM KH2PO4 (stock 2) until pH is 7.2 
Stock 4.  Prepare 250mM Sucrose/1mM EDTA solution by dissolving 42.8g of 
sucrose and 186mg of disodium EDTA in 500ml of potassium phosphate buffer 
(stock 3).  pH again to 7.2 (use KOH or HCl) 
 
 
2.  Preparation of homogenization buffer 
Stock Solutions 10 mL 
Buffer 
50 mL 
Buffer 
Company cat. # Storage 
250 mM Sucrose/ 
1mM EDTA 
solution (stock 4) 
9.4 mL 47 mL K2HPO4 & KH2PO4 (Sigma) 
Sucrose (Sigma S7903) 
EDTA (disodium) Sigma ED4SS 
Frozen 
Triton X-100 10% 100 µl 500 µl Peroxidase free 
Calbiochem 648464 
Frozen 
1M DTT  
 
10 µl 50 µl Sigma D9779 Made fresh  
10 mM Sodium 
orthovanadate 
100 µl 500 µl Sigma S6508 Frozen 
Protease inhibitor 400 µl 2 mL Sigma P8340 Add just 
before use 
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Coomassie Protein Assay 
 
Equipment: 
Microtiter plate reader (A595) 
 
Reagents: 
Coomassie Plus Protein Assay Kit Pierce 23236 
•  contains Coomassie Blue stain 
• BSA standards (2mg/ml) 
 
Procedure: 
1. Prepare BSA standards: 
2µg/µl (in kit) 
500µl of 2µg/µl + 500µl ddH2O = 1µg/µl 
125µl of 2µg/µl + 875µl ddH2O = 0.25µg/µl 
(this is sufficient for only one set of standards) 
2. Prepare microcentrifuge tubes of standards and samples in triplicate.  (Add 
Coomassie to all tubes last.) 
 
Standards: 
µg 
protein 
0.25µg/µl 
BSA 
1µg/µl 
BSA 
2µg/µl 
BSA 
Water Homog. 
Buffer 
Coomassie 
Reagent 
0 0µl - - 498.75µl 1.25 µl 500µl 
1 4µl - - 494.75µl   
2 - 2µl - 496.75µl   
4 - 4µl - 494.75µl   
10 - 10µl - 488.75µl   
20 - - 10µl 488.75µl   
   
Samples: 
Amt. of 
sample 
Water Coomassie 
Reagent 
1.25µl 498.75µl 500µl 
 
3. Incubate samples in Coomassie at RT for 10 minutes. 
4. Transfer 300µl of each tube to the appropriate well on a microtiter plate. 
5. Read absorbance (A595) on microtiter plate reader. 
(Absorbances for standards generally range from 0.3 to 1.0.) 
6. Plot standard curve (absorbance vs. µg protein).  Most plate readers will do this 
for you. 
7. Use readout of “unknowns” to determine protein concentration of samples. 
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Superoxide Dismutase Assay 
Cayman Chemicals 
Catalog #706002 
Range of Kit is 0.025-0.25 units/ml SOD 
Contents of Kit 
1. Assay Buffer (10X) 
2. Sample Buffer (10X) 
3. Radical Detector 
4. SOD (standard) 
5. Xanthine Oxidase 
6. 96 Well Plate 
7. Plate Cover 
Additional Items Required 
1. Potassium Cyanide (needed for measuring mitochondrial SOD) 
2. Plate Reader with 450nm filter 
3. Adjustable pipettors and a repeat pipettor 
4. Glass distilled water or HPLC-grade water 
 
Pre-Assay Preparation 
1. Assay Buffer-(10X)-(Vial #1) 
a. Dilute 3 ml of Assay Buffer with 27 ml of HPLC-grade water 
Assay buffer is used to dilute Radical Detector  
• Store at 4°C-Stable for 2 Months 
 
2. Sample Buffer-(10X)-(Vial #2) 
a. Dilute 3 ml of Sample Buffer concentrate with 27 ml of HPLC-grade 
water 
b.Final Sample Buffer should be used to prepare the SOD standards and 
dilute xanthine oxidase and SOD samples prior to assaying  
• Store at 4°C-Stable for 2 Months 
 
3. Radical Detector-(Vial #3) 
a. Put 19.95 ml of diluted Assay Buffer in a vial. 
b. Transfer 50 µl of tetrazolium salt to vial, but not until right before you are 
about to add to wells. 
c. Cover with Foil (light sensitive) 
• Stable for 2 hours on ice 
 
4. SOD standard-(Vial #4) 
a. Bovine Erythrocyte SOD(Cu/Zn) 
i. Ready to use as supplied 
ii. Store thawed enzyme on ice 
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5. Xanthine Oxidase (Vial #5) 
a. Thaw one vial 
i. Do not refreeze thawed enzyme  
b. Transfer 50 µl of enzyme to another vial 
c. Dilute with 1.95 ml of diluted Sample Buffer 
• Stable for 1 hour on ice 
 
Performing the SOD Assay 
 
i. The Assay temp is 25 C and absorbance is at 450 nm. 
ii. All reagents except samples and xanthine oxidase must be equilibrated to room 
temperature before beginning the assay. 
 
1. Prepartation of SOD Standards: 
a. Dilute 20 µl of SOD standard (vial #4) with 1.98 ml of diluted Sample 
buffer to each tube as described below: 
b.  
Tube SOD Stock (µl) Sample Buffer (µl) Final SOD Activity (U/ml) 
A* 0 1,000 0 
B 20 980 0.025 
C 40 960 0.05 
D 80 920 0.1 
E 120 880 0.15 
F 160 840 0.2 
G 200 800 0.25 
* just add 10 µl of Sample Buffer to Standard A wells instead of making a tube 
 
2. SOD Standard Wells 
a. Add 200 µl of diluted Radical Detector and 10 µl of Standard (tubes A-
G) in designated wells on plate. 
b. For blanks, just add 210 µl of HPLC-graded water to well. 
 
3. Sample Wells 
a. Add 200 µl of diluted Radical Detector and 10 µl of sample (in ratio 
desired). 
      OR 
b. Add 190 µl of diluted Radical Detector, 10 µl of inhibitor (KCN), & 10 
µl of sample. 
 
4. Initiate the reaction by adding 20 µl of diluted xanthine oxidase to all wells. 
a. Note precise time when started. 
b. Add as quickly as possible 
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5. Shake plate for 5 seconds to mix and cover with plate cover. 
6. Incubate on a shaker for 20 min at room temperature. 
7. Read absorbance at 450 nm using a plate reader. 
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Calculating Results of SOD Assay 
1. Calculate average absorbance of each standard and sample 
2. Divide Standard A’s absorbance by itself and divide standard A’s absorbance by 
all the other standards and samples absorbances to yield the linearized rate (LR) 
a. (i.e. LR for Std A= Abs Std A/ Abs Std. A;  LR for Std B=Abs Std A/ Abs 
Std B) 
3.Plot the linearized SOD standard rate (LR) as a function of final SOD Activity 
(U/ml) from Table 4.Calculate the SOD activity of the samples using the equation 
obtained from the linear regression of the standard curve substituting the linearized 
rate (LR) for each sample.   
b. One unit is defined as the amount of enzyme needed to exhibit 50% 
dismutation of superoxide radical. 
c. SOD(U/ml)= [(Sample LR-y-intercept/slope)x (0.23ml/0.01ml)] x sample 
dilution 
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Catalase  Assay Kit 
Calbiochem # 219265 
 
Materials Provided: 
10X Assay Buffer 
10X Sample Buffer 
Formaldehyde Standard Kit 
Catalase Control 
Potassium Hydroxide 
Methanol 
Hydrogen Peroxide 
Purpald 
Potassium Periodate 
96 Well Plate and Plate Sealer 
 
Materials Required but not Provided: 
Plate Reader (540 nm filter) 
Adjustable Pipettor 
Repeat Pipettor 
Distilled or HPLC-grade water 
 
Reagent Preparation 
1. 10X Assay Buffer 
a. Dilute 2ml 10X Assay Buffer with 18ml of HPLC-grade water 
b. This is 1X Assay Buffer to be used in Assay 
c. Store at 4°C-Stable for at least 2 months 
2. 10X Sample Buffer 
a. Dilute 5 ml of 10X Sample Buffer with 45 ml HPLC-grade water 
b. This is 1X Sample Buffer should be used to dilute standards, controls, 
samples prior to assaying 
c. Store at 4°C-Stable for at least 2 months 
3. Catalase (Control) 
a. Add 2 ml of 1X Sample Buffer and Vortex well 
b. Take 100µl of reconstituted enzyme and dilute with 1.9ml of 1X Sample 
Buffer 
c. Diluted enzyme is stable for 30 min 
d. Reconstituted CAT is stable for one month at -20°C 
4. Potassium Hydroxide 
a. Place vial on ice, add 4ml cold HPLC-grade water and vortex 
b. Store at 4°C stable for at least 3 months 
5. Hydrogen peroxide 
a. Dilute 40µl Hydrogen Peroxide with 9.96 ml HPLC-grade water 
b. Dilute Hydrogen Peroxide solution is stable for 2h. 
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Performing the CAT Assay: 
1)  Prepare Formaldehyde Standards 
a) Dilute 10µl of Formaldehyde Standard with 9.99 ml 1X Sample Buffer 
b) Add the amount of Formaldehyde Standard and 1X Sample Buffer to each tube 
as laid out below 
 
 
Tube Formaldehyde 
Stock (µl) 
Sample 
Buffer (µl) 
Final Concentration 
(µM formaldehyde) 
A 0 1000 0 
B 10 990 5 
C 30 970 15 
D 60 940 30 
E 90 910 45 
F 120 880 60 
G 150 850 75 
2)  Formaldehyde Standard Wells 
a) Add 100µl 1X Assay Buffer 
b) 30µl Methanol  
c) 20µl Formaldehyde Standards (tubes A-G) 
3)  Positive Control 
a) Add 100µl 1X Assay Buffer 
b) Add 30µl Methanol  
c) Add 20µl diluted Catalase Control 
 
4)  Sample Wells 
a) Add 100µl 1X Assay Buffer 
b) Add 30µl Methanol  
c) Add 20µl sample 
 
5)  Initiate the reactions by adding 20 µl dilute Hydrogen Peroxide to all wells. 
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a) Note time Started 
 
6)  Cover Plate with plate sealer and incubate on shaker for 20 min at room temp. 
 
7)  Add 30µl Potassium Hydroxide to each well to terminate reaction. 
 
8)  Add 30µl of Purpald to each well. 
 
9)  Cover plate with plate sealer and incubate for 10 min at room temp. on shaker. 
 
10)  Add 10µl Potassium Periodate to each well.  Cover with plate sealer and incubate at 
room temp. on shaker for 5 min. 
 
11) Read absorbance at 540nm. 
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Calculating Results of Catalase Assay 
 
 
1) Calculate avg. absorbance for each standard or sample 
 
2) Subtract avg. absorbance of standard A from itself and all other standards and 
samples. 
 
3) Plot corrected absorbance of standards as a function of final formaldehyde 
concentration 
 
4) Calculate the formaldehyde concentration of the samples using the equation 
obtained from the linear regression of the standard curve substituting corrected 
absorbance values for each sample 
 
a. Formaldehyde (µM)=(Sample absorbance - y-intercept/ slope) x(0.17 
ml/0.02 ml) 
 
5) Calculate Catalase Activity of the Sample using the following equation 
a. One unit is defined as the amount of enzyme that will cause the formation 
of 1.0 nmol formaldehyde per min at 25°C 
b. CAT Activity = (µM of sample/20 min)x Sample dilution = nmol/min/ml 
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Glutathione Peroxidase Assay Protocol 
Calbiochem: Cat. #353919 
 
Glutathione peroxidase (GPx) catalyzes the reduction of hydroperoxides, including 
hydrogen peroxide, by reduced glutathione and functions to protect the cell from 
oxidative damage. 
R-O-O-H + 2GSH R-O-H + GSSG + H2O 
 
GSSG + NADPH 2GSH + NADP+ 
 
 
Contents of Kit 
1. Assay Buffer (10x) 
2. Sample Buffer (10x) 
3. Glutathione Peroxidase (Control) 
4. Co-Substrate Mixture (3 vials) 
5. Cumene Hydroperoxide 
6. 96 Well Plate & Plate Cover 
 
Additional Items Required: 
1. Plate reader 
2. Adjustable pipettors & repeat pipettor 
3. Glass distilled or HPLC-grade water 
 
Reagent Preparation: 
1. Assay Buffer (10x) 
a. Dilute 2 ml Assay Buffer concentrate with 18 ml HPLC-grade water. 
b. Used in the assay. 
c. Store at 4°C.  Stable for 2 months. 
 
2. Sample Buffer (10x) 
a. Dilute 2 ml Sample Buffer concentrate with 18 ml HPLC-grade water. 
b. Used to dilute GPx Control and Samples prior to assaying. 
c. Store at 4°C.  Stable for 2 months. 
 
3. Glutathione Peroxidase (Control) 
a. To avoid repeated freezing and thawing, this should be put into small 
aliquots and stored at -20°C. 
b. For assay, dilute 10 	l of the GPx Control with 490 	l of dilute Sample 
Buffer and keep on ice. 
c. Stable for 4 hours on ice. 
d. A 20 	l aliquot of diluted GPx per well causes a decrease of ~ 0.051 
absorbance unit/minute. 
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4. Co-Substrate Mixture 
a. Add 2 ml of HPLC-grade water to vial and vortex well. 
b. Each reconstituted vial will be enough reagent for 40 wells. 
c. The reconstituted reagent should be kept at 25°C while assaying. 
d. Store at 4°C.  Stable for 2 days. 
 
5. Cumene Hydroperoxide 
a. Ready to use as supplied. 
b. Store at -20°C. 
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Performing the GPx Assay: 
 The assay temperature is 25°C.  Prepare all wells in triplicate. 
 
1. Background Wells 
a. Add 120 	l dilute Assay Buffer. 
b. Add 50 	l Co-Substrate Mixture. 
 
2. Positive Control Wells 
a. Add 100 	l dilute Assay Buffer. 
b. Add 50 	l Co-Substrate Mixture. 
c. Add 20 ul dilute GPx Control. 
 
3. Sample Wells 
a. Add 100 	l dilute Assay Buffer. 
b. Add 50 	l Co-Substrate Mixture. 
c. Add 20 ul sample. 
 
4. Initiate the reaction by adding 20 	l Cumene Hydroperoxide to all the wells. 
a. Note precise time when started. 
b. Add as quickly as possible. 
 
5. Carefully shake the plate for a few seconds to mix. 
 
6. Read the absorbance once every minute at 340 nm. 
a. Obtain at least 5 time points. 
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Calculating Results of Glutathione Peroxidase Assay 
 
1. Determine the change in absorbance (A340) per minute by: 
a. Plotting the absorbance values as a function of time to obtain the slope. 
 
-OR- 
 
b. Select two points on the linear portion of the curve and determine the 
change in absorbance during that time using the following equation: 
 
 
A340/min =  A340 (Time 2) - A340 (Time 1) 
 Time 2 (min) - Time 1 (min) 
 
2. Determine the rate of A340/min. for the background or non-enzymatic wells and 
subtract this rate from that of the sample wells.  Use the following formula to 
calculate the Glutathione peroxidase activity. The reaction rate at 340 nm can be 
determined using the NADPH extinction coefficient of 0.00373 	M-1. One unit is 
defined as the amount of enzyme that will cause the oxidation of 1.0 nmol of 
NADPH to NADP+/min at 25°C. 
 
 
 GPx Activity =    A340/min        x    0.19ml     x   Sample dilution =  nmol/min/ml 
      0.00373 µM-1        0.02ml      
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HPLC Analysis of GSH, GSSG, Cysteine and Cystine 
Modified By Kim Paulhill 7/2007 
The principle: the reduced form of glutathione (GSH) an the oxidized form of 
glutathione (GSSG), as well as cystine and cysteine, are derivatized with dansyl chloride 
in the presence of iodoacetic acid and KOH/teraborate (pH 9.0) to yield fluorescence 
derivatives.  The derivatives are separated by HPLC and quantified using fluorescence 
detection. 
 
1. Chemicals: 
a. Sodium Heparin       
b. Bathophenanthroline Disulfonate Sodium Salt (BPDS)  
c. Iodoacetic Acid       
d. Dansyl Chloride       
e. L-serine        
f. GSH         
g. GSSG 
h. Cystine 
i. Cysteine               
j. Sodium Acetate Trihydrate      
k. Boric Acid 
l. Sodium Tetra Borate 
 
2. Preparation of Solvents and Reagents: 
a. 100 mM Boric Acid:  Dissolve 3.1g boric acid in 500ml HPLC H20 
b. 100 mM Sodium Tetraborate:  Dissolve 19.1g sodium tetraborate in 500ml 
HPLC H20 
 
i. Solution A (Presevation Solution):   
1. Dissolve 1.05g L-Serine 
2. 50 mg sodium Heparin 
3. 100 mg BPDS 
4. 200 mg  iodoacetic acid 
5. in 80 ml of 100mM boric acid 
6. 20 ml of 100mM sodium tetraborate 
7. Solution is stable at -80°C for 6 months 
8. (Note: Heparin to inhibit coagulation, serine⋅borate to inhibit 
degradation of GSH by (-glutamyltranspeptidase, 
bathophenanthroline disulfonate to inhibit GSH oxidation, and 
iodoacetic acid to alkylate GSH). 
 
ii. Solution B (10% perchloric acid, w/v; 0.2 M boric acid): 
1. Dissolve 6.2 g boric acid in 300 ml HPLC water 
2. Add 71 ml of 70% perchloric acid 
3. quiesce to 500ml with HPLC water  
 
 82 
iii. Derivatization solutions: 
1. KOH/tetrahydroborate solution (pH 9.0): 
a. Add 5.6 g KOH  
b. to a plastic bottle containing 50g K2B4O7⋅4H20 and 
100ml HPLC water 
c. Mix- (Stable indefinitely at 25°C) 
2. Iodoacetic Acid: 
a. Dissolve 14.8 mg iodoacetic acid in 2ml of HPLC water 
b. Made fresh the day of derivatization 
3. Dansyl chloride: 
a. Dissolve 200mg dansyl chloride in 10ml of HPLC 
acetone 
b. Made fresh the day of derivatization 
 
3. GSH, GSSG, Cystine, and Cysteine standards: 
a. 2 mM GSH, GSSG, Cys, and Cystine: 
i. Dissolve 6.16 mg GSH 
ii. 12.2 mg GSSG 
iii. 2.44 mg cysteine 
iv. 4.8 mg cystine 
v. In 5ml of Sol A + 5ml of Solution B 
b. 500 nmol/ml GSH, GSSG, Cys, and Cystine: 
i. Mix 50µl of 2 mM standards 
ii. With 75µl of Sol A+ 75µl of Sol B 
c. 50 nmol/ml GSH, GSSG, Cys, and Cystine: 
i. Mix 50µl of 2 mM standards 
ii. With 975µl of Sol A+ 975µl of Sol B 
d. Blank (0 nmol/ml): 
i.  Mix  200µl of Sol A+ 200µl of Sol B 
 
4. Extraction of Glutathione from Tissue 
a. Tissue Homgenization for small sample size;(~ 5 to 10 mg tissue) 
i. Homogenize the tissue in 0.1 ml Sol A+ 0.1 ml Sol B 
ii. Rinse Homogenizer with 0.1 ml Sol A + 0.1 ml Sol B 
iii. Combine Homogenates 
iv. Centrifuge all tubes at 10,000 g for 1 min. 
v. Use supernatant for derivatization 
5. Derivatization 
a. Add to 1.5 ml microcentrifuge tube (use amber tubes): 
i. 150µl of standards (0, 50, 500 nmol/ml) or samples 
ii. 30µl of Iodoacetic acid solution 
iii. 100µl of KOH/tetraborate sol. (pH ~9) 
iv. Vortex and wait 20 min 
b. Add 150µl of dansyl chloride solution to each tube 
i. Vortex 
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ii. Keep all tubes in dark at room temp. for 16 h. 
c. Add 250µl of HPLC-grade chloroform to each tube(to extract the free 
dansyl-Cl) 
i. Vortex and centrifuge at 10,000 g for 1 min 
ii. (The dansyl derivatives are stable in the dark at 0-4°C for 12 
months) 
iii. Use upper aqueous layer for HPLC analysis 
d. Add 100µl of sample (or standard) derivatives to a micro-insert tube in a 
brown vial 
i. Vortex 
ii. Injection volume: 25µl 
6. HPLC Analysis 
a. HPLC solvents: 
i. Solvent A (Acetic Acid Buffer, pH 4.6) 
1. 640 ml Methanol + 200 ml Acetate stock solution +125 ml 
Glacial acetic acid + 50 ml HPLC water 
2. (Acetate Stock solution: Dissolve 272 g sodium acetate 
trihydrate in 122 ml HPLC water and 378 ml glacial 
acetic acid) 
ii. Solvent B (80% Methanol; v/v): 
1. 800 ml HPLC Methanol + 200 ml HPLC water 
b. HPLC Column: 3-Aminopropyl column (5 um; 4.6 x 250 mm) 
i. Custom LC, Houston, TX: Tel 800-537-9339) 
c. HPLC solvent gradient: 
     Solvent                                         Time(min) 
                                                                          0     10     30     33     33.1     38 
                                      Solvent A (%)             20   20     80     80     20        20 
                                      Solvent B (%)             80   80     20     20     80        80 
Flow rate: 1.0 ml/min 
    
Fluorescence detection (Waters 2475 Multi λ Fluorescence Detector): 
0.0 to 7.5 min: 590 nm excitation; 610 nm emission 
7.5 to 38 min:  335 nm excitation; 610 nm emission 
    
Gain: 10 (0 to 32.2 min): 100 (32.2 to 38 min).   
 (For liver samples) 
Gain: 100 (0 to 32.2 min): 1000 (32.2 to 38 min).  
 (For other samples)  
 Attenuation: 1 
 Retention time: Cys-16.7 min, Cysteine-20.1 min, GSH- 29.4 min, GSSG- 38 Min 
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Chemicals & supplies needed: 
Name Supplier & Catalog # 
Sodium Heparin Sigma H4784 
Bathophenanthroline disulfonate sodium salt (BPDS) Sigma B1375 
Iodoacetic acid Sigma I2512 
Dansyl chloride Sigma 39220 (Fluka) 
L-serine Sigma S4500 
GSH standard Sigma G6529 
GSSG standard Sigma G6654 
Cystiene Standard Sigma C-7352 
Cystine Standard Sigma C122009 
Sodium acetate trihydrate Sigma 236500 
Boric acid Sigma B0394 
Sodium tetraborate Sigma 221732 
70% Perchloric acid Fisher A469 
HPLC grade water Fisher W7 
Potassium hydroxide (KOH) Sigma P5958 
Potassium tetraborate tetrahydrate Sigma P5754 
Acetone Fisher A949 
Chloroform Sigma 650498 
Glacial acetic acid Bio/Bio 
Methanol (HPLC grade) Fisher A452 
3-aminopropyl column CEL Associates #132-204 
Ph# 800-537-9339 
Pearland, TX 
 
Other supplies & equipment needed: 
balance tweezers 
1.5 ml eppi tubes (2/sample) ice & ice chest 
vortex mini vortexer 
mini centrifuge HPLC glass vials with springs, inserts & lids 
pipet and tips calculator 
HPLC insert tubes Waters   Wat72030 
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PCNA methodology 
 
Staining protocol using the sequenza slide rack (Shandon, Pittsburgh, PA) 
 
Reagents: 
 
1.  Phosphate buffered saline (PBS) 
2.  Vectastain ABC Elite Kit -- mouse IgG 
 source: Vector Lab. 
 Cat #: PK-6102, 1 ml/ea. 
 contains: blocking serum 
 biotinylated antimouse IgG 
 avidin-biotin complex 
3.  PCNA monoclinal antibody (anti-PC10, murine) 
 source: Signet lab 
 Cat #: 523-01, 1ml/ea 
ps. Each new lot # of anti-PC10 must be tested with a 1:50, 1:100, 1:150, 1:200 
dilution series.  Prepare anitbody dilution with PBS, under sterile conditions.  
Use 4 micro thick single serial sections of colonic tissue to test the antibody 
dilutions.  Record the optimal dilution for the lot # tested. 
4.  Diaminobenzidine or DAB-tetrahydrochloride 
 source: Sigma 
 Cat #: D-5637 
 Prepare DAB stock solution, 50 mg/ml in H2O. Store as  
2 ml aliquots at -20° C. 
5.  Harris hematoxylin 
 
Critical steps prior to staining: 
1.  tissue fixation in 70% ethanol. 
2.  processing and baking of tissue at temperatures not exceeding 50° C. 
3.  keep slides moist at all times during the staining procedure. 
4.  include one positive and one negative control slide in each batch of slides stained. 
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Performing the PCNA Assay: 
 
1.  Deparaffinize slides 
 xylene---------------5' x 3 
 100% EtOH--------5' x 2 
 95% EtOH---------3' x 2 
 70% EtOH---------3' 
 H2O ---------------3' 
 
2.  Leave slides in 3% H2O2 for 30 min to remove endogenous peroxidase activity. 
 3% H2O2: 20 ml of 30% H2O2 made up to a final volume of 200 ml with 
methanol. 
 
3.  Wash in PBS 5 min, 3 times. 
 Mount slides onto coverplates using PBS and insert into sequenza. 
 
4.  Prepare Vectastain Blocking Serum by adding 3 drops of stock Normal Serum 
(yellow label) to 10 ml of PBS in yellow mixing bottle. 
 
5.  Add 3 drops* to each coverplate in sequenza and replace top to maintain humidity.  
Let stand for 20 min. 
 
6.  Wash with PBS by filling each coverplate in the sequenza with one ml of PBS. 
 
7.  Add 150 µl of anti-PC10 (use the optimal dilution obtained by dilution series: 1:200) 
to each coverplate in sequenza and replace top.  For the negative control slide use PBS 
instead of anti-PC10.  Let stand for 1 hour. 
 
8.  Wash with PBS by filling each coverplate in the sequenza to the top with PBS.  Let 
stand for 5 min. 
 
9.  Prepare Vectastain biotynylated anti-mouse IgG by mixing 3 drops of stock normal 
serum with 10 ml PBS in Blue mixing bottle, then add 1 drop of stock biotinylated 
antibody (blue labe), Mix Gently.  (or use 5 ml of serum solution form step 4, mix with 
25 µl of stock biotinylated antibody) 
 
10.  Add 3 drops to each coverplate in sequenza and replace top.  Let stand for 45 min.   
 
11.  Prepare ABC reagent in advance to be used in step 13.  The ABC reagent is 
prepared by adding 2 drops of reagent A (gray label) to 5 ml PBS in the ABC Reagent 
large mixing bottle.  Then add exactly 2 drops of Reagent B (gray label) to the same 
mixing bottle, mix immediately, and allow ABC Reagent to stand for about 30 minutes 
before use.  This should be done in a darkened area. 
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* Note: 1 drop = 50 µl 
12.  Wash with PBS by filling each coverplate in the sequenza to the top with PBS.  Let 
stand for 5 min. 
 
13.  Apply Vectastain ABC reagent that had been prepared in step 11.  Add 3 drops to 
each coverplate in sequenza, replace top, and let stand for 30 min. 
 
14.  Wash with PBS by filling each coverplate in the sequenza to the top with PBS.  
Remove slides form sequenza and place in PBS for 5 min. 
 
15.  Prepare DAB solution 
 For 200 ml: 2 ml stock DAB (50 mg/ml) 
  bring volume up to 200 ml with PBS 
 Immediately before staining, add 100 :l 30% H2O2. 
 
16.  Leave slides in DAB solution for 1 min, agitate twice. 
 
17.  Wash with H2O 5 min, 3 times. 
 
18.  Deactivate all DAB materials (glassware, pipet tips, used stock vials, stir bars) and 
used DAB solutions with bleach overnight, and flush with excess water in drain next 
day. 
 
19.  Counterstain with Hematoxyline  < 1 sec. 
 
20.  Wash with H2O 2 min, 2 times. 
 
21.  Dehydrate slides: 
 1 x 1 min 70% ETOH. 
 1 x 1 min 95% ETOH. 
 1 x 1 min 100% ETOH. 
 1 x 2 min Xylene. 
 
22.  Apply permount and cover glass.  Use the wet mounting method. 
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Apoptosis – ApopTag 
Modified by Lisa Sanders for NSBRI initiation study 
Used by Jayme Lewis for Sorghum Project 
Original Protocol:  ApopTag Kit with modifications by Wen-Chi Chang & April Carney 
02/2006 
 
Note:  To be performed on 4%PFA fixed tissue. 
 
***Put 200 ml PBS for Prot. K in 37° C oven and begin bleach rinse. 
 
___1.  Deparaffinize and rehydrate tissue: 
 ___Xylene, 3X, 5 min 
        let xylene just dry, circle sections w/ PAP pen, dry 1 min 
 ___100% EtOH, 2X, 5 min 
 ___95% EtOH, 1X, 3 min 
 ___70% EtOH, 1X, 3 min 
 ___PBS, 1X, 5 min 
(Get Equilibration Buffer and Reaction Buffer out of freezer-put on ice) 
 
___2.  Pretreat tissue – 3 min, in 37° 
 Proteinase K (10 µg/ml PBS)  = 0.1 ml Proteinase K (Ambion # 2546) in 
200 ml PBS. 
 
___3.  Wash in dH2O, 2x, 2 min 
 
___4.  Quench Endogenous Peroxidase: 0.3% H2O2 in 100% Methanol: 
3.0 ml 30% H2O2 in 297 ml 100% Methanol or 2.0 ml in 198 ml(add fresh H2O2 
immediately before quenching).  30 min, RT 
 
___5.  Wash in dH2O, 2x, 5 min 
  
___6.  Wash all slides in PBS 5 min. 
 
___7.  Gently tap off PBS and carefully blot around sections.  (Do this step and 
following step one slide at a time to avoid drying out sections.) 
 
___8.  Apply EQUILIBRATION BUFFER to all sections:  incubate in humidified 
chamber for 15 sec to 1 hr @ RT. 
 (# of slides X 150 µl) (9 slides X 150µl = 1.35 ml) 
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___9.  Tap off equilibration buffer and immediately apply REACTION BUFFER (- 
controls) or working strength TdT Enzyme with dilution ratio 1/10 (enzyme 
/reaction buffer).  (Get TdT directly from freezer & keep on ice) 
 
Apply only reaction buffer to  – control sections: 
___(# sections) X 40µl 
 
For normal sample sections (# sections X 40µl): 
___1080 µl  reaction buffer (for 9 slides) 
___36 µl TdT enzyme (for 9 slides) 
 
Incubate in a humidified chamber at 37°C, 1 hr 
(Prepare Stop/Wash so it can warm to RT.) 
 
___12. Put slides in coplin jar with Working Strength Stop/Wash Buffer (1ml + 34 ml 
dH2O).  Agitate for 15 sec; incubate 10 min, RT. 
Take aliquot of ANTI-DIGOXIGENIN PEROXIDASE (# slides X 125 µl) and 
allow to warm to room temperature (9 slides x 125µl = 1.125ml) 
 
___14.  Wash slides in PBS, 3X, 1min 
 
___15.  Blot dry the slides quickly (do one slide at a time) and apply ANTI-
DIGOXIGENIN PEROXIDASE to all sections; incubate 30 min. in humidity 
chamber @ RT. 
 
___16.  Wash in PBS 4X, 2min 
Prepare DAB peroxidase (1:50, substrate:dilution buffer) (#slides x 150µl) and 
warm to room temperature.  Protect from light. (9 slides X 150µl = 1350µl = 
27µl substrate:1323µl dilution buffer) 
 
___17.  Blot dry the slides quickly (do one slide at a time) and stain sections with DAB 
until light brown color shows up  (< 1 min). 
 
___18.  Wash in dH2O, 3X, 1 min  
 Leave in 4th  for 5 min 
 
___19. Counterstain w/ Methyl Green (reusable): 
 Dip quickly into Methyl green 
 Rinse in dH2O 5X; dip 1x in the 1st 2 changes and briefly agitate 
Dip 10 x in 3rd & leave ~ 30 sec. 
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Leave in the last 2 for 1 min w/o agitation 
 
___20.Dehydrate: ALL FRESH 
__70% EtOH, 1X, 1 min 
__95% EtOH, 1X, 1 min 
__100% EtOH, 1X, 1 min 
__Xylene: 3X, 2 min  (dip 10 times/ea) 
 
___21. Wet mount w/ Permount (80:20, Permount:Xylene) – leave overnight to dry 
 
 
reagent  company          catalog # 
Apotag Kit:  Chemicon    S7101 
Proteinase K  Ambion   2546 
PBS   Life Technologies  21600-069  
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APPENDIX B 
DATA TABLES 
 
 
TABLE 5 
Weight Gain Data1 
 
 
 
 
 
 
1Average weight gain data of rats over 48 hr time period at wk 2, 7, and 10.  Data 
are means ± SEM for n=10 rats/diet.  Means without common letter differ (p < 
0.02). 
 
 
 
TABLE 6 
Feed Efficiency Data1 
 
 
 
 
 
 
1Feed efficiency data of rats at three different time points.  Data are means ± SEM 
for n=10 rats/diet.  Means without common letter differ (p < 0.03). 
 
 
 
 
 Weight Gain 
 Wk 2 Wk 7 Wk 10 
Diet g/24 h 
Cellulose 5.766 ± 0.323a 2.886 ± 0.433a,b 1.891 ± 0.459a 
White Sorghum 6.168 ± 0.323a 3.438 ± 0.433a 1.767 ± 0.459a 
Black Sorghum 6.312 ± 0.323a 1.894 ± 0.433b 1.036 ± 0.459a 
Brown Sorghum 6.323 ± 0.323a 2.885 ± 0.433a,b 1.070 ± 0.459a 
 Feed Efficiency 
Diet Wk 2 Wk 7 Wk 10 
Cellulose 0.350 ± 0.016a 0.157 ± 0.021a,b 0.107 ± 0.027a 
White Sorghum 0.369 ± 0.016a 0.177 ± 0.021a 0.098 ± 0.027a 
Black Sorghum 0.391 ± 0.016a 0.111 ± 0.021b 0.063 ± 0.027a 
Brown Sorghum 0.374 ± 0.016a 0.163 ± 0.021a,b 0.058 ± 0.027a 
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TABLE 7 
Crypt Height1 
 
 
 
 
 
 
 
 
1Total number of cells/crypt.  Data are means ± SEM for n=10 
rats/diet. Means without common letter differ (p < 0.05). 
 
 
 
 
TABLE 8 
Total Number of Light Stained Cells in Proliferation1 
 
 
 
 
 
1Total number of light stained cells/crypt.  Data are means ± SEM for 
n=10 rats/diet.  No means differ. 
 
 
 
Diet Crypt Height 
 # cells/crypt 
Cellulose 31.93 ± 0.495a 
White Sorghum 32.24 ± 0.495a,b 
Black Sorghum 32.35 ± 0.495a,b 
Brown Sorghum 33.36 ± 0.495b 
Diet Light Stained Cells in Proliferation 
 # cells/crypt 
Cellulose 3.092 ± 0.380a 
White Sorghum 2.812 ± 0.380a 
Black Sorghum 2.784 ± 0.380a 
Brown Sorghum 3.500 ± 0.380a 
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TABLE 9 
Total Number of Stained Cells in Proliferation1 
 
 
 
 
 
1Total number of stained cells/crypt.  Data are means ± SEM for n=10 
rats/diet.  No means differ. 
 
 
 
TABLE 10 
Total Proliferative Index1 
 
 
 
 
 
1Total number of stained cells (light and dark combined)/total number 
of cells in crypt.  Data are means ± SEM for n=10 rats/diet.  No means 
differ. 
 
 
 
 
Diet Light Stained Cells in Proliferation 
 # cells/crypt 
Cellulose 7.500 ± 0.819a 
White Sorghum 6.052 ± 0.819a 
Black Sorghum 5.280 ± 0.819a 
Brown Sorghum 6.928 ± 0.819a 
Diet Total Proliferative Index 
 # cells/crypt height 
Cellulose 23.89 ± 2.497a 
White Sorghum 19.56 ± 2.497a 
Black Sorghum 17.15 ± 2.497a 
Brown Sorghum 21.31 ± 2.497a 
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TABLE 11 
Apoptotic Index of Bottom Tertile1 
 
 
 
1Apoptotic cells/total number of cells in crypt in bottom tertile.  Data 
are means ± SEM for n=10 rats/diet.  No means differ. 
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FIGURE 32 Apoptotic Index vs. Antioxidant Activity.  Four experimental diets were fed to 40 
AOM-injected rats (n=10/diet).  The antioxidant activity of the diets was measured by 2,2'-azino-
bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS) method.  Apoptotic index was calculated 
from the distal colon of all animals with the TUNEL assay.  There was a tendency for apoptotic 
index to increase as antioxidant activity in the diet increased (p < 0.07). 
 
 
 
Diet Apoptotic Index in Bottom Tertile 
 # cells/crypt height 
Cellulose 2.538 ± 0.735a 
White Sorghum 2.108 ± 0.735a 
Black Sorghum 2.727 ± 0.735a 
Brown Sorghum 3.564 ± 0.735a 
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